##	TAG	<div1>
##	TAG	<head>
##	TAG	<name>
1	TOK	Randomised	BOS	Randomised\N46
##	TAG	</name>
2	TOK	trial		trial\N5S
3	TOK	of		of\P
4	TOK	irinotecan		irinotecan\N5S
5	TOK	plus		plus\CS
6	TOK	supportive		supportive\JA
7	TOK	care		care\N5S
##	TAG	<foreign lang="LA" pos="P">
8	TOK	versus		versus\P
##	TAG	</foreign>
9	TOK	supportive		supportive\JA
10	TOK	care		care\N5S
11	TOK	alone		alone\DGA7
12	TOK	after		after\P
13	TOK	fluorouracil		fluorouracil\N5S
14	TOK	failure		failure\N5S
15	TOK	for		for\P
16	TOK	patients		patient\N5P
17	TOK	with		with\P
18	TOK	metastatic		metastatic\JA
19	TOK	colorectal		colorectal\JA
20	TOK	cancer	EOS	cancer\N5S
##	TAG	</head>
##	TAG	<head>
22	TOK	Introduction	BOS	introduction\N5S
tf	TOK		EOS	=\DELS
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
24	TOK	Colorectal	BOS	colorectal\JA
25	TOK	cancer		cancer\N5S
26	TOK	is		be\V6FDRS3
27	TOK	one		one\MCS
28	TOK	of		of\P
29	TOK	the		the\AT---6
30	TOK	most		most\DDS7
31	TOK	common		common\JA
32	TOK	adult		adult\N5S
33	TOK	malignant		malignant\JA
34	TOK	tumours		tumour\N5P
---	DLD	,		=\DELIM
35	TOK	affecting		affect\VMG----
36	TOK	one		one\MCS
37	TOK	person		person\N5S
38	TOK	in		in\P
##	TAG	<num>
39	TOK	twenty		twenty\X
##	TAG	</num>
40	TOK	in		in\P
41	TOK	the		the\AT---6
##	TAG	<name>
42	TOK	USA		USA\N46
##	TAG	</name>
43	TOK	and		and\CC
44	TOK	in		in\P
45	TOK	most		most\AG---6
46	TOK	developed		develop\VMC----
47	TOK	countries		country\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
48	TOK	Although	BOS	although\CS
##	TAG	<num>
49	TOK	40-50		40-50\X
##	TAG	</num>
---	DLD	%		=\DELIM
50	TOK	patients		patient\N5P
51	TOK	may		may\VOFDR66
52	TOK	be		be\VMI----
53	TOK	cured		cure\VMC----
54	TOK	with		with\P
55	TOK	surgery		surgery\N5S
---	DLD	,		=\DELIM
56	TOK	many		many\RIP3N-
57	TOK	will		will\VOFDR66
58	TOK	develop		develop\VMI----
59	TOK	metastatic		metastatic\JA
60	TOK	disease		disease\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
61	TOK	For	BOS	for\P
62	TOK	these		this\AD---P
63	TOK	patients		patient\N5P
---	DLD	,		=\DELIM
64	TOK	treatment		treatment\N5S
65	TOK	with		with\P
66	TOK	fluorouracil		fluorouracil\N5S
---	DLD	,		=\DELIM
67	TOK	usually		usually\DGA7
68	TOK	modulated		modulate\VMC----
69	TOK	by		by\P
70	TOK	folinic		folinic\JA
71	TOK	acid		acid\N5S
---	DLD	,		=\DELIM
72	TOK	is		be\V6FDRS3
73	TOK	the		the\AT---6
74	TOK	only		only\JA
75	TOK	option		option\N5S
76	TOK	and		and\CC
77	TOK	the		the\AT---6
78	TOK	median		median\N5S
79	TOK	survival		survival\N5S
80	TOK	is		be\V6FDRS3
##	TAG	<na type="function">
81	TOK	10-12		noanat\W
##	TAG	</na>
82	TOK	months		month\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
83	TOK	When	BOS	when\CS
84	TOK	the		the\AT---6
85	TOK	tumour		tumour\N5S
86	TOK	progresses		progress\VMFDRS3
87	TOK	after		after\P
88	TOK	first		first\MOS
89	TOK	line		line\N5S
90	TOK	treatment		treatment\N5S
91	TOK	with		with\P
92	TOK	fluorouracil		fluorouracil\N5S
---	DLD	,		=\DELIM
93	TOK	there		there\DGA7
94	TOK	is		be\V6FDRS3
95	TOK	no		no\AI---6
96	TOK	standard		standard\JA
97	TOK	treatment		treatment\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
98	TOK	Survival	BOS	survival\N5S
99	TOK	is		be\V6FDRS3
100	TOK	short		short\JA
101	TOK	and		and\CC
102	TOK	associated		associate\VMC----
103	TOK	with		with\P
104	TOK	weight		weight\N5S
105	TOK	loss		loss\N5S
---	DLD	,		=\DELIM
106	TOK	onset		onset\N5S
107	TOK	or		or\CC
108	TOK	worsening		worsen\VMG----
109	TOK	of		of\P
110	TOK	tumour		tumour\N5S
---	DLI	-		=\DELIM
111	TOK	related		relate\VMC----
112	TOK	symptoms		symptom\N5P
---	DLD	,		=\DELIM
113	TOK	and		and\CC
114	TOK	poor		poor\JA
115	TOK	quality		quality\N5S
116	TOK	of		of\P
117	TOK	life		life\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
118	TOK	Because	BOS	because\CS
119	TOK	cytotoxic		cytotoxic\JA
120	TOK	agents		agent\N5P
121	TOK	have		have\V6F6R66
122	TOK	low		low\JA
123	TOK	response		response\N5S
124	TOK	rates		rate\N5P
125	TOK	and		and\CC
126	TOK	can		can\VOFDR66
127	TOK	be		be\VMI----
128	TOK	associated		associate\VMC----
129	TOK	with		with\P
130	TOK	severe		severe\JA
131	TOK	side		side\N5S
---	DLI	-		=\DELIM
132	TOK	effects		effect\N5P
---	DLD	,		=\DELIM
133	TOK	many		many\AI---P
134	TOK	patients		patient\N5P
135	TOK	receive		receive\VMF6R66
136	TOK	supportive		supportive\JA
137	TOK	care		care\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
138	TOK	In	BOS	in\P
139	TOK	first		first\MOS
---	DLI	-		=\DELIM
140	TOK	line		line\N5S
141	TOK	chemotherapy		chemotherapy\N5S
---	DLD	,		=\DELIM
142	TOK	fluorouracil		fluorouracil\N5S
143	TOK	with		with\P
144	TOK	folinic		folinic\JA
---	DLI	-		=\DELIM
145	TOK	acid		acid\N5S
146	TOK	is		be\V6FDRS3
147	TOK	better		good\JC
148	TOK	than		than\CS
149	TOK	supportive		supportive\JA
150	TOK	care		care\N5S
---	DLE	(		=\DELIM
151	TOK	or		or\CC
152	TOK	delayed		delay\VMF6A66
153	TOK	chemotherapy		chemotherapy\N5S
---	DLD	)		=\DELIM
154	TOK	for		for\P
155	TOK	survival		survival\N5S
156	TOK	and		and\CC
157	TOK	quality		quality\N5S
158	TOK	of		of\P
159	TOK	life		life\N5S
---	DLD	,		=\DELIM
160	TOK	but		but\CC
161	TOK	the		the\AT---6
162	TOK	value		value\N5S
163	TOK	of		of\P
164	TOK	second		second\MOS
165	TOK	line		line\N5S
166	TOK	chemotherapy		chemotherapy\N5S
167	TOK	in		in\P
168	TOK	metastatic		metastatic\JA
169	TOK	colorectal		colorectal\JA
170	TOK	cancer		cancer\N5S
171	TOK	has		have\V6FDRS3
172	TOK	not		not\DGA7
173	TOK	yet		yet\DGA7
174	TOK	been		be\VMC----
175	TOK	proven		prove\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
176	TOK	Irinotecan	BOS	Irinotecan\N46
##	TAG	</name>
177	TOK	is		be\V6FDRS3
178	TOK	a		a\AI---S
179	TOK	topoisomerase		topoisomerase\N5S
180	TOK	I		i\N5S
181	TOK	inhibitor		inhibitor\N5S
182	TOK	that		that\RW63N6
183	TOK	blocks		block\VMFDRS3
184	TOK	the		the\AT---6
##	TAG	<name>
185	TOK	DNA		DNA\N46
##	TAG	</name>
186	TOK	replication		replication\N5S
187	TOK	step		step\N5S
188	TOK	of		of\P
189	TOK	the		the\AT---6
190	TOK	enzyme		enzyme\N5S
---	DLD	,		=\DELIM
191	TOK	leading		leading\JA
192	TOK	to		to\P
193	TOK	multiple		multiple\JA
194	TOK	single		single\JA
---	DLI	-		=\DELIM
195	TOK	strand		strand\N5S
##	TAG	<name>
196	TOK	DNA		DNA\N46
##	TAG	</name>
197	TOK	breaks		break\VMFDRS3
---	DLD	,		=\DELIM
198	TOK	which		which\RW63N-
199	TOK	eventually		eventually\DGA7
200	TOK	blocks		block\VMFDRS3
201	TOK	cell		cell\N5S
202	TOK	division		division\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
203	TOK	In	BOS	in\P
204	TOK	phase		phase\N5S
##	TAG	<num>
205	TOK	II		II\X
##	TAG	</num>
206	TOK	studies		study\N5P
---	DLD	,		=\DELIM
207	TOK	irinotecan		irinotecan\N5S
208	TOK	has		have\V6FDRS3
209	TOK	objective		objective\JA
210	TOK	antitumour		antitumour\JA
211	TOK	activity		activity\N5S
212	TOK	in		in\P
213	TOK	patients		patient\N5P
214	TOK	with		with\P
215	TOK	metastatic		metastatic\JA
216	TOK	colorectal		colorectal\JA
217	TOK	cancer		cancer\N5S
---	DLD	,		=\DELIM
218	TOK	even		even\DGA7
219	TOK	in		in\P
220	TOK	those		that\RDP3N-
221	TOK	with		with\P
222	TOK	documented		document\VMC----
223	TOK	fluorouracil		fluorouracil\N5S
---	DLI	-		=\DELIM
224	TOK	resistant		resistant\JA
225	TOK	tumours		tumour\N5P
---	DLD	,		=\DELIM
226	TOK	with		with\P
227	TOK	response		response\N5S
228	TOK	rates		rate\N5P
229	TOK	of		of\P
##	TAG	<num>
230	TOK	11-23		11-23\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
231	TOK	An	BOS	an\AI---S
232	TOK	additional		additional\JA
##	TAG	<na type="function">
233	TOK	40% of		noanat\W
##	TAG	</na>
234	TOK	patients		patient\N5P
235	TOK	experienced		experience\VMF6A66
236	TOK	tumour		tumour\N5S
237	TOK	stabilisation		stabilisation\N5S
238	TOK	for		for\P
239	TOK	a		a\AI---S
240	TOK	median		median\N5S
241	TOK	of		of\P
##	TAG	<num>
242	TOK	5		5\X
##	TAG	</num>
243	TOK	months		month\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
244	TOK	Common	BOS	common\JA
245	TOK	side		side\N5S
246	TOK	effects		effect\N5P
247	TOK	included		include\VMC----
248	TOK	delayed		delay\VMC----
249	TOK	diarrhoea		diarrhoea\N5S
---	DLD	,		=\DELIM
250	TOK	neutropenia		neutropenia\N5S
---	DLD	,		=\DELIM
251	TOK	early		early\JA
252	TOK	cholinergic		cholinergic\JA
253	TOK	syndrome		syndrome\N5S
---	DLD	,		=\DELIM
254	TOK	nausea		nausea\N5S
255	TOK	and		and\CC
256	TOK	vomiting		vomit\VMG----
---	DLD	,		=\DELIM
257	TOK	alopecia		alopecia\N5S
---	DLD	,		=\DELIM
258	TOK	and		and\CC
259	TOK	asthenia		asthenia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
260	TOK	The	BOS	the\AT---6
261	TOK	dose		dose\N5S
262	TOK	limiting		limit\VMG----
263	TOK	toxic		toxic\JA
264	TOK	effects		effect\N5P
265	TOK	were		be\V6F-A66
266	TOK	severe		severe\JA
267	TOK	diarrhoea		diarrhoea\N5S
268	TOK	and		and\CC
269	TOK	neutropenia		neutropenia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
270	TOK	The	BOS	the\AT---6
271	TOK	trial		trial\N5S
272	TOK	we		we\RPP1NN
273	TOK	report		report\N5S
274	TOK	was		be\V6F-A66
275	TOK	started		start\VMC----
276	TOK	in		in\P
##	TAG	<num>
277	TOK	1995		1995\X
##	TAG	</num>
278	TOK	to		to\P
279	TOK	compare		compare\VMI----
280	TOK	irinotecan		irinotecan\N5S
281	TOK	with		with\P
282	TOK	supportive		supportive\JA
283	TOK	care		care\N5S
284	TOK	alone		alone\DGA7
285	TOK	for		for\P
286	TOK	survival		survival\N5S
---	DLD	,		=\DELIM
287	TOK	quality		quality\N5S
288	TOK	of		of\P
289	TOK	life		life\N5S
---	DLD	,		=\DELIM
290	TOK	and		and\CC
291	TOK	other		other\JA
292	TOK	clinical		clinical\JA
293	TOK	variables		variable\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
294	TOK	The	BOS	the\AT---6
295	TOK	participants		participant\N5P
296	TOK	were		be\V6F-A66
297	TOK	patients		patient\N5P
298	TOK	with		with\P
299	TOK	metastatic		metastatic\JA
300	TOK	colorectal		colorectal\JA
301	TOK	cancer		cancer\N5S
302	TOK	in		in\P
303	TOK	whom		whom\RW63NA
304	TOK	fluorouracil		fluorouracil\N5S
305	TOK	chemotherapy		chemotherapy\N5S
306	TOK	had		have\V6F6A66
307	TOK	failed		fail\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
308	TOK	Methods	BOS	method\N5P
tf	TOK		EOS	=\DELS
##	TAG	</head>
##	TAG	<head>
310	TOK	Endpoints	BOS	endpoint\N5P
tf	TOK		EOS	=\DELS
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
312	TOK	Overall	BOS	overall\JA
313	TOK	survival		survival\N5S
314	TOK	was		be\V6F-A66
315	TOK	the		the\AT---6
316	TOK	primary		primary\JA
317	TOK	endpoint		endpoint\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
318	TOK	The	BOS	the\AT---6
319	TOK	secondary		secondary\JA
320	TOK	objectives		objective\N5P
321	TOK	were		be\V6F-A66
322	TOK	the		the\AT---6
323	TOK	impact		impact\N5S
324	TOK	of		of\P
325	TOK	treatment		treatment\N5S
326	TOK	on		on\P
327	TOK	performance		performance\N5S
328	TOK	status		status\N5S
---	DLD	,		=\DELIM
329	TOK	bodyweight		bodyweight\N5P
---	DLD	,		=\DELIM
330	TOK	tumour		tumour\N5S
---	DLI	-		=\DELIM
331	TOK	related		relate\VMC----
332	TOK	symptoms		symptom\N5P
---	DLD	,		=\DELIM
333	TOK	and		and\CC
334	TOK	quality		quality\N5S
335	TOK	of		of\P
336	TOK	life		life\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
337	TOK	Patients	BOS	patient\N5P
---	DLD	'		=\DELIM
338	TOK	selection	EOS	selection\N5S
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
339	TOK	To	BOS	to\P
340	TOK	be		be\VMI----
341	TOK	eligible		eligible\JA
342	TOK	for		for\P
343	TOK	randomisation		randomisation\N5P
---	DLD	,		=\DELIM
344	TOK	patients		patient\N5P
345	TOK	had		have\V6F6A66
346	TOK	to		to\P
347	TOK	meet		meet\VMI----
348	TOK	the		the\AT---6
349	TOK	following		following\JA
350	TOK	criteria		criterion\N5P
---	DLD	:		=\DELIM
351	TOK	histologically		histologically\DGA7
352	TOK	proven		prove\VMC----
353	TOK	metastatic		metastatic\JA
354	TOK	colorectal		colorectal\JA
355	TOK	cancer		cancer\N5S
---	DLD	;		=\DELIM
356	TOK	progressive		progressive\JA
357	TOK	metastatic		metastatic\JA
358	TOK	disease		disease\N5S
359	TOK	documented		document\VMC----
360	TOK	on		on\P
361	TOK	the		the\AT---6
362	TOK	basis		basis\N5S
363	TOK	of		of\P
364	TOK	either		either\RIP3N-
365	TOK	a		a\AI---S
##	TAG	<num>
366	TOK	25		25\X
##	TAG	</num>
---	DLD	%		=\DELIM
367	TOK	increase		increase\N5S
368	TOK	in		in\P
369	TOK	the		the\AT---6
370	TOK	size		size\N5S
371	TOK	of		of\P
372	TOK	target		target\N5S
373	TOK	lesions		lesion\N5P
374	TOK	or		or\CC
375	TOK	an		an\AI---S
376	TOK	increase		increase\N5S
377	TOK	in		in\P
378	TOK	carcinoembryonic		carcinoembryonic\JA
379	TOK	antigen		antigen\N5S
380	TOK	by		by\P
##	TAG	<na type="function">
381	TOK	1·25		noanat\W
##	TAG	</na>
382	TOK	times		time\N5P
383	TOK	an		an\AI---S
384	TOK	initial		initial\JA
385	TOK	reference		reference\N5S
386	TOK	value		value\N5S
387	TOK	and		and\CC
388	TOK	a		a\AI---S
389	TOK	baseline		baseline\N5S
390	TOK	value		value\N5S
391	TOK	of		of\P
392	TOK	more		more\DDC7
393	TOK	than		than\CS
394	TOK	10ugl/L		10ugl/L\N5P
---	DLE	,		=\DELIM
395	TOK	which		which\RW63N-
396	TOK	allowed		allow\VMF6A66
397	TOK	inclusion		inclusion\N5S
398	TOK	of		of\P
399	TOK	patients		patient\N5P
400	TOK	with		with\P
401	TOK	non		non\N5P
---	DLI	-		=\DELIM
402	TOK	measurable		measurable\JA
403	TOK	disease		disease\N5S
---	DLE	(		=\DELIM
404	TOK	peritoneal		peritoneal\JA
405	TOK	carcinomatosis		carcinomatosis\N5S
406	TOK	and		and\CC
407	TOK	pelvic		pelvic\JA
408	TOK	recurrences		recurrence\N5P
---	DLD	)		=\DELIM
---	DLD	;		=\DELIM
409	TOK	progression		progression\N5S
410	TOK	documented		document\VMC----
411	TOK	by		by\P
##	TAG	<num>
412	TOK	two		two\X
##	TAG	</num>
413	TOK	measurements		measurement\N5P
414	TOK	not		not\DGA7
415	TOK	separated		separate\VMC----
416	TOK	by		by\P
417	TOK	more		more\DDC7
418	TOK	than		than\CS
##	TAG	<num>
419	TOK	6		6\X
##	TAG	</num>
420	TOK	months		month\N5P
421	TOK	and		and\CC
422	TOK	tumour		tumour\N5S
423	TOK	progression		progression\N5S
424	TOK	while		while\CS
425	TOK	on		on\P
426	TOK	fluorouracil		fluorouracil\N5S
427	TOK	or		or\CC
428	TOK	within		within\P
##	TAG	<num>
429	TOK	6		6\X
##	TAG	</num>
430	TOK	months		month\N5P
431	TOK	of		of\P
432	TOK	the		the\AT---6
433	TOK	last		last\JA
434	TOK	fluorouracil		fluorouracil\N5S
435	TOK	infusion		infusion\N5S
---	DLD	;		=\DELIM
436	TOK	having		have\VMG----
437	TOK	had		have\VMC----
438	TOK	one		one\MCS
439	TOK	adjuvant		adjuvant\N5S
440	TOK	and/or		and/or\N5S
##	TAG	<loc pos="DGA7">
441	TOK	no more		no_more\DGA7
##	TAG	</loc>
442	TOK	than		than\CS
##	TAG	<num>
443	TOK	two		two\X
##	TAG	</num>
444	TOK	palliative		palliative\JA
445	TOK	fluorouracil		fluorouracil\N5S
---	DLI	-		=\DELIM
446	TOK	based		base\VMC----
447	TOK	regimens		regimen\N5P
---	DLD	;		=\DELIM
448	TOK	age		age\N5S
##	TAG	<na type="function">
449	TOK	18-75		noanat\W
##	TAG	</na>
450	TOK	years		year\N5P
---	DLD	;		=\DELIM
##	TAG	<name>
451	TOK	WHO		WHO\N46
##	TAG	</name>
452	TOK	performance		performance\N5S
453	TOK	status		status\N5S
##	TAG	<na type="function">
454	TOK	0-2		noanat\W
##	TAG	</na>
---	DLD	;		=\DELIM
455	TOK	neutrophils		neutrophil\N5P
456	TOK	2x10		2x10\N5P
##	TAG	<na type="function">
457	TOK	9/L		noanat\W
##	TAG	</na>
458	TOK	or		or\CC
459	TOK	more		more\DDC7
---	DLD	;		=\DELIM
460	TOK	platelets		platelet\N5P
461	TOK	100x10		100x10\N5P
##	TAG	<na type="function">
462	TOK	9/L		noanat\W
##	TAG	</na>
463	TOK	or		or\CC
464	TOK	more		more\DDC7
---	DLD	;		=\DELIM
465	TOK	total		total\JA
466	TOK	bilirubin		bilirubin\N5S
##	TAG	<na type="function">
467	TOK	1·25X		noanat\W
##	TAG	</na>
468	TOK	the		the\AT---6
469	TOK	institutional		institutional\JA
470	TOK	upper		upper\JA
471	TOK	normal		normal\JA
472	TOK	limit		limit\VMF6R66
---	DLE	(		=\DELIM
##	TAG	<name>
473	TOK	IUNL		IUNL\N46
##	TAG	</name>
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
474	TOK	or		or\CC
475	TOK	less		less\DDC7
---	DLD	;		=\DELIM
476	TOK	liver		liver\N5S
477	TOK	transaminases		transaminase\N5P
478	TOK	3xIUNL		3xIUNL\N5P
---	DLE	(		=\DELIM
479	TOK	in		in\P
480	TOK	case		case\N5S
481	TOK	of		of\P
482	TOK	liver		liver\N5S
483	TOK	metastases		metastasis\N5P
---	DLD	:		=\DELIM
484	TOK	bilirubin		bilirubin\N5S
485	TOK	xxx		noanat\W
486	TOK	and		and\CC
487	TOK	transaminases		transaminase\N5P
488	TOK	5xIUNL		5xIUNL\N5P
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
489	TOK	or		or\CC
490	TOK	more		more\DDC7
---	DLD	;		=\DELIM
491	TOK	serum		serum\N5S
492	TOK	creatinine		creatinine\N5S
##	TAG	<num>
493	TOK	135		135\X
##	TAG	</num>
494	TOK	&		&\CC
495	TOK	mgr;mol/L		mgr;mol/L\N5S
496	TOK	or		or\CC
497	TOK	less		less\N56
---	DLD	;		=\DELIM
498	TOK	wash		wash\N5S
---	DLI	-		=\DELIM
499	TOK	out		out\DGA7
500	TOK	of		of\P
##	TAG	<num>
501	TOK	4		4\X
##	TAG	</num>
502	TOK	weeks		week\N5P
503	TOK	for		for\P
504	TOK	radiotherapy		radiotherapy\N5S
505	TOK	or		or\CC
506	TOK	chemotherapy		chemotherapy\N5S
---	DLD	;		=\DELIM
507	TOK	and		and\CC
508	TOK	written		write\VMC----
509	TOK	informed		inform\VMC----
510	TOK	consent		consent\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
511	TOK	Patients	BOS	patient\N5P
512	TOK	with		with\P
513	TOK	the		the\AT---6
514	TOK	following		following\JA
515	TOK	criteria		criterion\N5P
516	TOK	were		be\V6F-A66
517	TOK	not		not\DGA7
518	TOK	eligible		eligible\JA
---	DLD	:		=\DELIM
519	TOK	previous		previous\JA
520	TOK	treatment		treatment\N5S
521	TOK	with		with\P
522	TOK	topoisomerase		topoisomerase\N5S
523	TOK	I		i\N5S
524	TOK	inhibitors		inhibitor\N5P
---	DLD	,		=\DELIM
525	TOK	bulky		bulky\JA
526	TOK	disease		disease\N5S
---	DLE	(		=\DELIM
527	TOK	involving		involve\VMG----
528	TOK	more		more\DDC7
529	TOK	than		than\CS
##	TAG	<na type="function">
530	TOK	50% of		noanat\W
##	TAG	</na>
531	TOK	the		the\AT---6
532	TOK	liver		liver\N5S
533	TOK	volume		volume\N5S
534	TOK	or		or\CC
##	TAG	<na type="function">
535	TOK	25% of		noanat\W
##	TAG	</na>
536	TOK	the		the\AT---6
537	TOK	lung		lung\N5S
538	TOK	volume		volume\N5S
---	DLD	,		=\DELIM
539	TOK	or		or\CC
540	TOK	abdominal		abdominal\JA
541	TOK	mass		mass\N5S
##	TAG	<num>
542	TOK	>10		>10\X
##	TAG	</num>
543	TOK	cm		cm\N5P
---	DLD	)		=\DELIM
---	DLD	,		=\DELIM
544	TOK	metastases		metastasis\N5P
545	TOK	in		in\P
546	TOK	the		the\AT---6
547	TOK	central		central\JA
548	TOK	nervous		nervous\JA
549	TOK	system		system\N5S
---	DLD	,		=\DELIM
550	TOK	or		or\CC
551	TOK	unresolved		unresolved\JA
552	TOK	bowel		bowel\N5S
553	TOK	obstruction		obstruction\N5S
554	TOK	or		or\CC
555	TOK	diarrhoea		diarrhoea\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
##	TAG	<name>
556	TOK	Randomisation	BOS	Randomisation\N46
##	TAG	</name>
557	TOK	and		and\CC
558	TOK	study		study\N5S
559	TOK	treatments	EOS	treatment\N5P
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
561	TOK	Registration	BOS	registration\N5S
562	TOK	forms		form\N5P
563	TOK	were		be\V6F-A66
564	TOK	sent		send\VMC----
565	TOK	to		to\P
##	TAG	<name>
566	TOK	Rhône-Poulenc Rorer Research		Rhône-Poulenc_Rorer_Research\N46
##	TAG	</name>
567	TOK	and		and\CC
##	TAG	<name>
568	TOK	Development		Development\N46
##	TAG	</name>
---	DLE	(		=\DELIM
##	TAG	<name>
569	TOK	Antony		Antony\N46
##	TAG	</name>
---	DLE	,		=\DELIM
##	TAG	<name>
570	TOK	France		France\N46
##	TAG	</name>
---	DLE	)		=\DELIM
571	TOK	where		where\CS
572	TOK	eligibility		eligibility\N5S
573	TOK	criteria		criterion\N5P
574	TOK	were		be\V6F-A66
575	TOK	electronically		electronically\DGA7
576	TOK	checked		check\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
577	TOK	If	BOS	if\CS
578	TOK	all		all\AG---6
579	TOK	criteria		criterion\N5P
580	TOK	were		be\V6F-A66
581	TOK	fulfilled		fulfill\VMC----
---	DLD	,		=\DELIM
582	TOK	the		the\AT---6
583	TOK	randomisation		randomisation\N5S
584	TOK	was		be\V6F-A66
585	TOK	done		do\VMC----
586	TOK	electronically		electronically\DGA7
587	TOK	in		in\P
588	TOK	the		the\AT---6
589	TOK	ratio		ratio\N5S
590	TOK	of		of\P
591	TOK	irinotecan		irinotecan\N5S
592	TOK	to		to\P
593	TOK	supportive		supportive\JA
594	TOK	care		care\N5S
##	TAG	<num>
595	TOK	2:1		2:1\X
##	TAG	</num>
---	DLE	,		=\DELIM
596	TOK	with		with\P
597	TOK	stratification		stratification\N5S
598	TOK	by		by\P
599	TOK	centre		centre\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
600	TOK	In	BOS	in\P
601	TOK	the		the\AT---6
602	TOK	irinotecan		irinotecan\JA
603	TOK	group		group\N5S
---	DLD	,		=\DELIM
604	TOK	patients		patient\N5P
605	TOK	were		be\V6F-A66
606	TOK	given		give\VMC----
607	TOK	best		good\DDS7
608	TOK	supportive		supportive\JA
609	TOK	care		care\N5S
610	TOK	and		and\CC
611	TOK	irinotecan		irinotecan\JA
##	TAG	<num>
612	TOK	350		350\X
##	TAG	</num>
##	TAG	<loc pos="N56">
613	TOK	mg/m2		mg/m2\N56
##	TAG	</loc>
---	DLE	,		=\DELIM
614	TOK	diluted		dilute\VMC----
615	TOK	in		in\P
##	TAG	<num>
616	TOK	250		250\X
##	TAG	</num>
##	TAG	<loc pos="N56">
617	TOK	mL		mL\N56
##	TAG	</loc>
618	TOK	normal		normal\JA
619	TOK	saline		saline\N5S
620	TOK	or		or\CC
621	TOK	dextrose		dextrose\N5S
---	DLD	,		=\DELIM
622	TOK	over		over\P
623	TOK	a		a\AI---S
##	TAG	<num>
624	TOK	90		90\X
##	TAG	</num>
625	TOK	min		min\N5S
626	TOK	intravenous		intravenous\JA
627	TOK	infusion		infusion\N5S
628	TOK	every		every\AG---S
##	TAG	<num>
629	TOK	3		3\X
##	TAG	</num>
630	TOK	weeks		week\N5P
---	DLE	(		=\DELIM
631	TOK	or		or\CC
##	TAG	<num>
632	TOK	300		300\X
##	TAG	</num>
##	TAG	<loc pos="N56">
633	TOK	mg/m2		mg/m2\N56
##	TAG	</loc>
634	TOK	if		if\CS
635	TOK	aged		age\VMF6A66
##	TAG	<num>
636	TOK	>70		>70\X
##	TAG	</num>
637	TOK	years		year\N5P
638	TOK	or		or\CC
##	TAG	<name>
639	TOK	WHO		WHO\N46
##	TAG	</name>
640	TOK	performance		performance\N5S
641	TOK	status		status\N5S
##	TAG	<num>
642	TOK	2		2\X
##	TAG	</num>
---	DLE	,		=\DELIM
##	TAG	<loc pos="P">
643	TOK	according to		according_to\P
##	TAG	</loc>
644	TOK	previously		previously\DGA7
645	TOK	recognised		recognise\VMC----
646	TOK	risk		risk\N5S
647	TOK	factors		factor\N5P
648	TOK	for		for\P
649	TOK	developing		developing\JA
650	TOK	toxicity		toxicity\N5S
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
651	TOK	Guidelines	BOS	guideline\N5P
652	TOK	were		be\V6F-A66
653	TOK	provided		provide\VMC----
654	TOK	for		for\P
655	TOK	the		the\AT---6
656	TOK	management		management\N5S
657	TOK	of		of\P
658	TOK	side		side\N5S
659	TOK	effects		effect\N5P
---	DLE	(		=\DELIM
660	TOK	panel		panel\N5S
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
661	TOK	Treatment	BOS	treatment\N5S
662	TOK	was		be\V6F-A66
663	TOK	to		to\P
664	TOK	be		be\VMI----
665	TOK	started		start\VMC----
##	TAG	<loc pos="DGA7">
666	TOK	no longer		no_longer\DGA7
##	TAG	</loc>
667	TOK	than		than\CS
##	TAG	<num>
668	TOK	8		8\X
##	TAG	</num>
669	TOK	days		day\N5P
670	TOK	after		after\P
671	TOK	randomisation		randomisation\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
672	TOK	In	BOS	in\P
673	TOK	the		the\AT---6
674	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
675	TOK	care		care\N5S
676	TOK	alone		alone\DGA7
677	TOK	group		group\VMF6R66
---	DLD	,		=\DELIM
678	TOK	patients		patient\N5P
679	TOK	were		be\V6F-A66
680	TOK	given		give\VMC----
681	TOK	best		good\DDS7
682	TOK	supportive		supportive\JA
683	TOK	care		care\N5S
684	TOK	and		and\CC
685	TOK	were		be\V6F-A66
686	TOK	seen		see\VMC----
687	TOK	every		every\AG---S
##	TAG	<num>
688	TOK	3		3\X
##	TAG	</num>
689	TOK	weeks		week\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
690	TOK	Supportive	BOS	supportive\JA
691	TOK	care		care\N5S
692	TOK	was		be\V6F-A66
693	TOK	defined		define\VMC----
694	TOK	as		as\P
695	TOK	the		the\AT---6
696	TOK	best		good\JS
697	TOK	care		care\N5S
698	TOK	available		available\JA
699	TOK	as		as\CS
700	TOK	judged		judge\VMC----
701	TOK	by		by\P
702	TOK	the		the\AT---6
703	TOK	attending		attend\VMG----
704	TOK	physician		physician\N5S
---	DLD	,		=\DELIM
##	TAG	<loc pos="P">
705	TOK	according to		according_to\P
##	TAG	</loc>
706	TOK	institutional		institutional\JA
707	TOK	standards		standard\N5P
708	TOK	for		for\P
709	TOK	each		each\AG---S
710	TOK	centre		centre\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
711	TOK	Supportive	BOS	supportive\JA
712	TOK	care		care\N5S
713	TOK	included		include\VMF6A66
714	TOK	antibiotics		antibiotic\N5P
---	DLD	,		=\DELIM
715	TOK	analgesics		analgesic\N5P
---	DLD	,		=\DELIM
716	TOK	transfusions		transfusion\N5P
---	DLD	,		=\DELIM
717	TOK	corticosteroids		corticosteroid\N5P
---	DLD	,		=\DELIM
718	TOK	or		or\CC
719	TOK	any		any\AG---6
720	TOK	other		other\JA
721	TOK	symptomatic		symptomatic\JA
722	TOK	therapy		therapy\N5S
---	DLE	(		=\DELIM
723	TOK	except		except\P
724	TOK	irinotecan		irinotecan\JA
725	TOK	or		or\CC
726	TOK	other		other\JA
727	TOK	topoisomerase		topoisomerase\N5S
728	TOK	I		i\N5S
729	TOK	inhibitor		inhibitor\N5S
---	DLD	)		=\DELIM
---	DLD	,		=\DELIM
730	TOK	and/or		and/or\N5S
731	TOK	assistance		assistance\N5S
732	TOK	of		of\P
733	TOK	a		a\AI---S
734	TOK	psychotherapist		psychotherapist\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
735	TOK	Localised	BOS	localise\VMC----
736	TOK	radiation		radiation\N5S
737	TOK	therapy		therapy\N5S
738	TOK	to		to\P
739	TOK	alleviate		alleviate\VMI----
740	TOK	symptoms		symptom\N5P
741	TOK	such		such\RIS3N-
742	TOK	as		as\P
743	TOK	pain		pain\N5S
744	TOK	was		be\V6F-A66
745	TOK	allowed		allow\VMC----
746	TOK	provided		provide\VMC----
747	TOK	that		that\CS
748	TOK	the		the\AT---6
749	TOK	total		total\JA
750	TOK	dose		dose\N5S
751	TOK	delivered		deliver\VMC----
752	TOK	was		be\V6F-A66
753	TOK	in		in\P
754	TOK	the		the\AT---6
755	TOK	palliative		palliative\JA
756	TOK	range		range\N5S
##	TAG	<loc pos="P">
757	TOK	according to		according_to\P
##	TAG	</loc>
758	TOK	institutional		institutional\JA
759	TOK	standards		standard\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
760	TOK	Analysis	BOS	analysis\N5S
761	TOK	of		of\P
762	TOK	best		good\JS
763	TOK	supportive		supportive\JA
764	TOK	care	EOS	care\N5S
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
766	TOK	Supportive	BOS	supportive\JA
767	TOK	care		care\N5S
768	TOK	and		and\CC
769	TOK	concomitant		concomitant\JA
770	TOK	medications		medication\N5P
771	TOK	were		be\V6F-A66
772	TOK	reported		report\VMC----
773	TOK	at		at\P
774	TOK	each		each\AG---S
775	TOK	visit		visit\VMF6R66
---	DLE	(		=\DELIM
776	TOK	every		every\AG---S
##	TAG	<num>
777	TOK	3		3\X
##	TAG	</num>
778	TOK	weeks		week\N5P
779	TOK	in		in\P
780	TOK	both		both\RIP3N-
781	TOK	groups		group\N5P
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
782	TOK	They	BOS	they\RPP3NN
783	TOK	were		be\V6F-A66
784	TOK	classified		classify\VMC----
785	TOK	with		with\P
786	TOK	the		the\AT---6
##	TAG	<name>
787	TOK	WHO		WHO\N46
##	TAG	</name>
788	TOK	dictionary		dictionary\N5S
---	DLD	;		=\DELIM
789	TOK	further		further\JA
790	TOK	subclassification		subclassification\N5S
791	TOK	was		be\V6F-A66
792	TOK	done		do\VMC----
793	TOK	with		with\P
794	TOK	the		the\AT---6
##	TAG	<name>
795	TOK	WHO		WHO\N46
##	TAG	</name>
796	TOK	code		code\N5S
797	TOK	for		for\P
798	TOK	anatomical		anatomical\JA
799	TOK	therapeutic		therapeutic\JA
800	TOK	class		class\N5S
---	DLE	(		=\DELIM
##	TAG	<name>
801	TOK	ATC		ATC\N46
##	TAG	</name>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
802	TOK	With	BOS	with\P
803	TOK	these		this\AD---P
804	TOK	classifications		classification\N5P
---	DLD	,		=\DELIM
805	TOK	analgesics		analgesic\N5P
806	TOK	were		be\V6F-A66
807	TOK	divided		divide\VMC----
808	TOK	into		into\P
809	TOK	opioids		opioid\N5P
810	TOK	or		or\CC
811	TOK	non		non\N5P
---	DLD	-		=\DELIM
812	TOK	opioids		opioid\N5P
813	TOK	and		and\CC
814	TOK	analysed		analyse\VMC----
815	TOK	in		in\P
##	TAG	<num>
816	TOK	3		3\X
##	TAG	</num>
---	DLE	-		=\DELIM
817	TOK	week		week\N5S
818	TOK	blocks		block\VMFDRS3
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
819	TOK	Follow	BOS	follow\VMF6R66
---	DLI	-		=\DELIM
820	TOK	up	EOS	up\N5S
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
822	TOK	Patients	BOS	patient\N5P
823	TOK	visited		visit\VMF6A66
824	TOK	the		the\AT---6
825	TOK	investigator		investigator\N5S
826	TOK	for		for\P
827	TOK	assessment		assessment\N5S
828	TOK	and		and\CC
829	TOK	treatment		treatment\N5S
830	TOK	every		every\AG---S
##	TAG	<num>
831	TOK	3		3\X
##	TAG	</num>
832	TOK	weeks		week\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
833	TOK	All	BOS	all\AG---6
834	TOK	adverse		adverse\JA
835	TOK	events		event\N5P
836	TOK	were		be\V6F-A66
837	TOK	reported		report\VMC----
##	TAG	<loc pos="P">
838	TOK	according to		according_to\P
##	TAG	</loc>
839	TOK	the		the\AT---6
##	TAG	<name pos="N46" type="organization">
840	TOK	National Cancer Institute		National_Cancer_Institute\N46
##	TAG	</name>
841	PGR	's		genmark\GENMARK
842	TOK	common		common\JA
843	TOK	toxicity		toxicity\N5S
844	TOK	criteria		criterion\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
845	TOK	After	BOS	after\P
846	TOK	discontinuation		discontinuation\N5S
847	TOK	of		of\P
848	TOK	treatment		treatment\N5S
849	TOK	in		in\P
850	TOK	the		the\AT---6
851	TOK	irinotecan		irinotecan\JA
852	TOK	group		group\N5S
---	DLD	,		=\DELIM
853	TOK	patients		patient\N5P
854	TOK	were		be\V6F-A66
855	TOK	regularly		regularly\DGA7
856	TOK	assessed		assess\VMC----
857	TOK	as		as\DGA7
858	TOK	in		in\P
859	TOK	the		the\AT---6
860	TOK	supportive		supportive\JA
861	TOK	care		care\N5S
862	TOK	group		group\VMF6R66
---	DLE	(		=\DELIM
863	TOK	tumour		tumour\N5S
864	TOK	status		status\N5S
---	DLD	,		=\DELIM
865	TOK	symptoms		symptom\N5P
---	DLD	,		=\DELIM
866	TOK	or		or\CC
867	TOK	side		side\N5S
---	DLI	-		=\DELIM
868	TOK	effects		effect\N5P
---	DLD	,		=\DELIM
869	TOK	every		every\AG---S
##	TAG	<num>
870	TOK	3		3\X
##	TAG	</num>
871	TOK	weeks		week\N5P
---	DLD	)		=\DELIM
872	TOK	until		until\P
873	TOK	death		death\N5S
874	TOK	or		or\CC
875	TOK	for		for\P
##	TAG	<loc pos="DGA7">
876	TOK	at least		at_least\DGA7
##	TAG	</loc>
877	TOK	a		a\AI---S
878	TOK	year		year\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
879	TOK	Beyond	BOS	beyond\P
##	TAG	<num>
880	TOK	1		1\X
##	TAG	</num>
881	TOK	year		year\N5S
---	DLD	,		=\DELIM
882	TOK	only		only\JA
883	TOK	date		date\N5S
884	TOK	of		of\P
885	TOK	death		death\N5S
886	TOK	was		be\V6F-A66
887	TOK	traced		trace\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
888	TOK	Quality	BOS	quality\N5S
889	TOK	of		of\P
890	TOK	life	EOS	life\N5S
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
892	TOK	Quality	BOS	quality\N5S
893	TOK	of		of\P
894	TOK	life		life\N5S
895	TOK	was		be\V6F-A66
896	TOK	assessed		assess\VMC----
897	TOK	with		with\P
898	TOK	the		the\AT---6
##	TAG	<name>
899	TOK	European Organization for Research		European_Organization_for_Research\N46
##	TAG	</name>
900	TOK	and		and\CC
##	TAG	<name>
901	TOK	Treatment of Cancer		Treatment_of_Cancer\N46
##	TAG	</name>
---	DLE	(		=\DELIM
##	TAG	<name>
902	TOK	EORTC		EORTC\N46
##	TAG	</name>
---	DLE	)		=\DELIM
##	TAG	<name>
903	TOK	QLQ-C30		QLQ-C30\N46
##	TAG	</name>
904	TOK	questionnaire		questionnaire\N5S
---	DLE	(		=\DELIM
905	TOK	including		including\P
##	TAG	<num>
906	TOK	five		five\X
##	TAG	</num>
907	TOK	function		function\N5S
908	TOK	scales		scale\N5P
---	DLD	,		=\DELIM
909	TOK	one		one\RIS3N-
910	TOK	global		global\JA
911	TOK	health		health\N5S
912	TOK	status		status\N5S
913	TOK	scale		scale\N5S
---	DLD	,		=\DELIM
914	TOK	and		and\CC
##	TAG	<num>
915	TOK	nine		nine\X
##	TAG	</num>
916	TOK	symptom		symptom\N5S
917	TOK	scales		scale\N5P
---	DLD	)		=\DELIM
---	DLD	,		=\DELIM
918	TOK	which		which\RW63N-
919	TOK	was		be\V6F-A66
920	TOK	filled		fill\VMC----
921	TOK	in		in\P
922	TOK	at		at\P
923	TOK	baseline		baseline\N5S
---	DLD	,		=\DELIM
924	TOK	at		at\P
##	TAG	<num>
925	TOK	3		3\X
##	TAG	</num>
926	TOK	weeks		week\N5P
---	DLD	,		=\DELIM
##	TAG	<num>
927	TOK	6		6\X
##	TAG	</num>
928	TOK	weeks		week\N5P
---	DLD	,		=\DELIM
929	TOK	and		and\CC
930	TOK	then		then\DGA7
931	TOK	every		every\AG---S
##	TAG	<num>
932	TOK	6		6\X
##	TAG	</num>
933	TOK	weeks		week\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
934	TOK	After	BOS	after\P
935	TOK	discontinuation		discontinuation\N5S
936	TOK	of		of\P
937	TOK	treatment		treatment\N5S
938	TOK	in		in\P
939	TOK	the		the\AT---6
940	TOK	irinotecan		irinotecan\JA
941	TOK	group		group\N5S
---	DLD	,		=\DELIM
942	TOK	patients		patient\N5P
943	TOK	continued		continue\VMC----
944	TOK	to		to\P
945	TOK	fill		fill\VMI----
946	TOK	in		in\P
##	TAG	<name>
947	TOK	QLQ-C30		QLQ-C30\N46
##	TAG	</name>
948	TOK	questionnaires		questionnaire\N5P
949	TOK	every		every\AG---S
##	TAG	<num>
950	TOK	6		6\X
##	TAG	</num>
951	TOK	weeks		week\N5P
952	TOK	as		as\CS
953	TOK	in		in\P
954	TOK	the		the\AT---6
955	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
956	TOK	care		care\N5S
957	TOK	group		group\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
958	TOK	Statistical	BOS	statistical\JA
959	TOK	analysis	EOS	analysis\N5S
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
961	TOK	Survival	BOS	survival\N5S
962	TOK	curves		curve\N5P
963	TOK	were		be\V6F-A66
964	TOK	estimated		estimate\VMC----
965	TOK	with		with\P
966	TOK	the		the\AT---6
##	TAG	<name>
967	TOK	Kaplan-Meier		Kaplan-Meier\N46
##	TAG	</name>
968	TOK	method		method\N5S
969	TOK	on		on\P
970	TOK	the		the\AT---6
971	TOK	randomised		randomised\JA
972	TOK	population		population\N5S
973	TOK	and		and\CC
974	TOK	compared		compare\VMC----
975	TOK	by		by\P
976	TOK	a		a\AI---S
977	TOK	two		two\MCP
---	DLI	-		=\DELIM
978	TOK	tailed		tail\VMC----
979	TOK	logrank		logrank\N5S
980	TOK	test		test\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
981	TOK	With	BOS	with\P
##	TAG	<na type="equation">
982	TOK	p=0·05		noanat\W
##	TAG	</na>
983	TOK	and		and\CC
984	TOK	power		power\N5S
985	TOK	of		of\P
##	TAG	<na type="function">
986	TOK	0·80		noanat\W
##	TAG	</na>
---	DLE	,		=\DELIM
##	TAG	<num>
987	TOK	264		264\X
##	TAG	</num>
988	TOK	patients		patient\N5P
989	TOK	were		be\V6F-A66
990	TOK	required		require\VMC----
---	DLE	(		=\DELIM
##	TAG	<num>
991	TOK	176		176\X
##	TAG	</num>
992	TOK	in		in\P
993	TOK	the		the\AT---6
994	TOK	irinotecan		irinotecan\JA
995	TOK	group		group\N5S
996	TOK	and		and\CC
##	TAG	<num>
997	TOK	88		88\X
##	TAG	</num>
998	TOK	in		in\P
999	TOK	the		the\AT---6
1000	TOK	supportive		supportive\JA
1001	TOK	care		care\N5S
1002	TOK	group		group\VMF6R66
---	DLD	)		=\DELIM
1003	TOK	to		to\P
1004	TOK	show		show\VMI----
1005	TOK	a		a\AI---S
1006	TOK	significant		significant\JA
1007	TOK	difference		difference\N5S
1008	TOK	in		in\P
##	TAG	<num>
1009	TOK	1		1\X
##	TAG	</num>
---	DLE	-		=\DELIM
1010	TOK	year		year\N5S
1011	TOK	survival		survival\N5S
1012	TOK	from		from\P
##	TAG	<num>
1013	TOK	20		20\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLE	(		=\DELIM
1014	TOK	supportive		supportive\JA
1015	TOK	care		care\N5S
---	DLD	)		=\DELIM
1016	TOK	to		to\P
##	TAG	<num>
1017	TOK	35		35\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLE	(		=\DELIM
1018	TOK	irinotecan		irinotecan\N5P
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1019	TOK	The	BOS	the\AT---6
1020	TOK	randomisation		randomisation\N5S
1021	TOK	was		be\V6F-A66
1022	TOK	stratified		stratify\VMC----
1023	TOK	by		by\P
1024	TOK	centre		centre\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1025	TOK	A	BOS	a\AI---S
1026	TOK	retrospective		retrospective\JA
1027	TOK	stratification		stratification\N5S
1028	TOK	was		be\V6F-A66
1029	TOK	planned		plan\VMC----
1030	TOK	to		to\P
1031	TOK	take		take\VMI----
1032	TOK	into		into\P
1033	TOK	account		account\VMI----
1034	TOK	the		the\AT---6
1035	TOK	baseline		baseline\N5S
1036	TOK	prognostic		prognostic\JA
1037	TOK	factors		factor\N5P
---	DLE	(		=\DELIM
1038	TOK	sex		sex\N5S
---	DLD	,		=\DELIM
1039	TOK	age		age\N5S
---	DLD	,		=\DELIM
1040	TOK	performance		performance\N5S
1041	TOK	status		status\N5S
---	DLD	,		=\DELIM
1042	TOK	weight		weight\N5S
1043	TOK	loss		loss\N5S
---	DLD	,		=\DELIM
1044	TOK	presence		presence\N5S
1045	TOK	of		of\P
1046	TOK	liver		liver\N5S
1047	TOK	metastases		metastasis\N5P
---	DLD	,		=\DELIM
1048	TOK	site		site\N5S
1049	TOK	of		of\P
1050	TOK	primary		primary\JA
1051	TOK	tumour		tumour\N5S
---	DLD	,		=\DELIM
1052	TOK	number		number\N5S
1053	TOK	of		of\P
1054	TOK	metastatic		metastatic\JA
1055	TOK	sites		site\N5P
---	DLD	,		=\DELIM
1056	TOK	response		response\N5S
1057	TOK	to		to\P
1058	TOK	and		and\CC
1059	TOK	duration		duration\N5S
1060	TOK	of		of\P
1061	TOK	fluorouracil		fluorouracil\N5S
1062	TOK	treatment		treatment\N5S
##	TAG	<loc pos="DGA7">
1063	TOK	as well as		as_well_as\DGA7
##	TAG	</loc>
1064	TOK	its		its\APS3N6
1065	TOK	intent		intent\N5S
---	DLE	[		=\DELIM
1066	TOK	adjuvant		adjuvant\JA
1067	TOK	or		or\CC
1068	TOK	palliative		palliative\JA
---	DLD	]		=\DELIM
---	DLD	,		=\DELIM
1069	TOK	haemoglobin		haemoglobin\N5S
---	DLD	,		=\DELIM
1070	TOK	white		white\JA
1071	TOK	blood		blood\N5S
1072	TOK	cells		cell\N5P
---	DLD	,		=\DELIM
1073	TOK	platelets		platelet\N5P
---	DLD	,		=\DELIM
1074	TOK	lactate		lactate\N5S
1075	TOK	dehydrogenase		dehydrogenase\N5S
---	DLD	,		=\DELIM
1076	TOK	transaminases		transaminase\N5P
---	DLD	,		=\DELIM
1077	TOK	alkaline		alkaline\JA
1078	TOK	phosphatase		phosphatase\N5S
---	DLD	,		=\DELIM
1079	TOK	bilirubin		bilirubin\N5S
---	DLD	,		=\DELIM
1080	TOK	protein		protein\N5S
---	DLD	,		=\DELIM
1081	TOK	and		and\CC
1082	TOK	carcinoembryonic		carcinoembryonic\JA
1083	TOK	antigen		antigen\N5S
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1084	TOK	The	BOS	the\AT---6
1085	TOK	analysis		analysis\N5S
1086	TOK	was		be\V6F-A66
1087	TOK	by		by\P
1088	TOK	intention		intention\N5S
1089	TOK	to		to\P
1090	TOK	treat		treat\VMI----
1091	TOK	and		and\CC
1092	TOK	patients		patient\N5P
1093	TOK	were		be\V6F-A66
1094	TOK	analysed		analyse\VMC----
##	TAG	<loc pos="P">
1095	TOK	according to		according_to\P
##	TAG	</loc>
1096	TOK	the		the\AT---6
1097	TOK	arm		arm\N5S
1098	TOK	to		to\P
1099	TOK	which		which\RW63N-
1100	TOK	they		they\RPP3NN
1101	TOK	were		be\V6F-A66
1102	TOK	assigned		assign\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1103	TOK	The	BOS	the\AT---6
1104	TOK	association		association\N5S
1105	TOK	of		of\P
1106	TOK	prognostic		prognostic\JA
1107	TOK	factors		factor\N5P
1108	TOK	with		with\P
1109	TOK	survival		survival\N5S
1110	TOK	was		be\V6F-A66
1111	TOK	estimated		estimate\VMC----
1112	TOK	with		with\P
##	TAG	<name>
1113	TOK	Cox		Cox\N46
##	TAG	</name>
1114	PGR	's		genmark\GENMARK
1115	TOK	proportional		proportional\JA
1116	TOK	hazards		hazard\N5P
1117	TOK	model		model\N5S
1118	TOK	for		for\P
1119	TOK	censored		censor\VMC----
1120	TOK	survival		survival\N5S
1121	TOK	data		data\N56
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1122	TOK	Model	BOS	model\N5S
1123	TOK	selection		selection\N5S
1124	TOK	for		for\P
1125	TOK	identifying		identify\VMG----
1126	TOK	the		the\AT---6
1127	TOK	variables		variable\N5P
1128	TOK	having		have\VMG----
1129	TOK	an		an\AI---S
1130	TOK	effect		effect\N5S
1131	TOK	on		on\P
1132	TOK	survival		survival\N5S
1133	TOK	was		be\V6F-A66
1134	TOK	based		base\VMC----
1135	TOK	on		on\P
1136	TOK	a		a\AI---S
1137	TOK	forward		forward\DGA7
1138	TOK	stepwise		stepwise\JA
1139	TOK	procedure		procedure\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1140	TOK	P	BOS	p\N5S
1141	TOK	values		value\N5P
1142	TOK	to		to\P
1143	TOK	enter		enter\VMI----
1144	TOK	and		and\CC
1145	TOK	to		to\P
1146	TOK	remove		remove\N5S
1147	TOK	were		be\V6F-A66
##	TAG	<na type="function">
1148	TOK	0·05		noanat\W
##	TAG	</na>
1149	TOK	and		and\CC
##	TAG	<na type="function">
1150	TOK	0·06		noanat\W
##	TAG	</na>
---	DLE	,		=\DELIM
1151	TOK	respectively		respectively\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1152	TOK	After	BOS	after\P
1153	TOK	the		the\AT---6
1154	TOK	prognostic		prognostic\JA
1155	TOK	model		model\N5S
1156	TOK	had		have\V6F6A66
1157	TOK	been		be\VMC----
1158	TOK	determined		determine\VMF6A66
---	DLD	,		=\DELIM
1159	TOK	the		the\AT---6
1160	TOK	effect		effect\N5S
1161	TOK	of		of\P
1162	TOK	treatment		treatment\N5S
1163	TOK	after		after\P
1164	TOK	adjusting		adjust\VMG----
1165	TOK	for		for\P
1166	TOK	other		other\JA
1167	TOK	prognostic		prognostic\JA
1168	TOK	factors		factor\N5P
1169	TOK	was		be\V6F-A66
1170	TOK	estimated		estimate\VMC----
1171	TOK	by		by\P
1172	TOK	including		include\VMG----
1173	TOK	it		it\RPS3N6
1174	TOK	in		in\P
1175	TOK	the		the\AT---6
1176	TOK	model		model\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1177	TOK	Survival	BOS	survival\N5S
1178	TOK	without		without\P
1179	TOK	weight		weight\N5S
1180	TOK	loss		loss\N5S
1181	TOK	of		of\P
1182	TOK	more		more\DDC7
1183	TOK	than		than\CS
##	TAG	<num>
1184	TOK	5		5\X
##	TAG	</num>
---	DLD	%		=\DELIM
1185	TOK	survival		survival\N5S
1186	TOK	without		without\P
1187	TOK	performance		performance\N5S
---	DLI	-		=\DELIM
1188	TOK	status		status\N5S
1189	TOK	deterioration		deterioration\N5S
---	DLD	,		=\DELIM
1190	TOK	and		and\CC
1191	TOK	pain		pain\N5S
---	DLI	-		=\DELIM
1192	TOK	free		free\JA
1193	TOK	survival		survival\N5S
1194	TOK	were		be\V6F-A66
1195	TOK	estimated		estimate\VMC----
1196	TOK	by		by\P
1197	TOK	the		the\AT---6
##	TAG	<name>
1198	TOK	Kaplan-Meier		Kaplan-Meier\N46
##	TAG	</name>
1199	TOK	method		method\N5S
1200	TOK	and		and\CC
1201	TOK	compared		compare\VMC----
1202	TOK	with		with\P
1203	TOK	a		a\AI---S
1204	TOK	two		two\MCP
---	DLD	-		=\DELIM
1205	TOK	tailed		tail\VMC----
1206	TOK	logrank		logrank\N5S
1207	TOK	test		test\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1208	TOK	Quality	BOS	quality\N5S
---	DLI	-		=\DELIM
1209	TOK	of		of\P
---	DLI	-		=\DELIM
1210	TOK	life		life\N5S
1211	TOK	variables		variable\N5P
1212	TOK	were		be\V6F-A66
1213	TOK	compared		compare\VMC----
1214	TOK	with		with\P
1215	TOK	multivariate		multivariate\JA
1216	TOK	and		and\CC
1217	TOK	univariate		univariate\JA
1218	TOK	analyses		analysis\N5P
1219	TOK	of		of\P
1220	TOK	variance		variance\N5S
1221	TOK	on		on\P
1222	TOK	values		value\N5P
1223	TOK	at		at\P
1224	TOK	baseline		baseline\N5S
---	DLD	,		=\DELIM
1225	TOK	during		during\P
1226	TOK	study		study\VMI----
---	DLD	,		=\DELIM
1227	TOK	on		on\P
1228	TOK	patients		patient\N5P
---	DLD	'		=\DELIM
1229	TOK	worst		bad\JS
1230	TOK	score		score\N56
1231	TOK	over		over\P
1232	TOK	the		the\AT---6
1233	TOK	trial		trial\N5S
1234	TOK	period		period\N5S
---	DLD	,		=\DELIM
1235	TOK	and		and\CC
1236	TOK	changes		change\N5P
1237	TOK	from		from\P
1238	TOK	baseline		baseline\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
1239	TOK	Kaplan-Meier	BOS	Kaplan-Meier\N46
##	TAG	</name>
1240	TOK	estimates		estimate\N5P
1241	TOK	and		and\CC
1242	TOK	logrank		logrank\N5S
1243	TOK	tests		test\N5P
1244	TOK	were		be\V6F-A66
1245	TOK	done		do\VMC----
1246	TOK	on		on\P
1247	TOK	time		time\N5S
1248	TOK	to		to\P
1249	TOK	definitive		definitive\JA
1250	TOK	quality		quality\N5S
---	DLI	-		=\DELIM
1251	TOK	of		of\P
---	DLI	-		=\DELIM
1252	TOK	life		life\N5S
1253	TOK	deterioration		deterioration\N5S
---	DLD	,		=\DELIM
1254	TOK	with		with\P
##	TAG	<num>
1255	TOK	eight		eight\X
##	TAG	</num>
1256	TOK	different		different\JA
1257	TOK	thresholds		threshold\N5P
1258	TOK	for		for\P
1259	TOK	deterioration		deterioration\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
1260	TOK	Results	BOS	result\N5P
tf	TOK		EOS	=\DELS
##	TAG	</head>
##	TAG	<head>
1262	TOK	Patients	BOS	patient\N5P
---	DLD	'		=\DELIM
1263	TOK	data	EOS	data\N56
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
##	TAG	<num>
1264	TOK	189	BOS	189\X
##	TAG	</num>
1265	TOK	patients		patient\N5P
1266	TOK	were		be\V6F-A66
1267	TOK	randomly		randomly\DGA7
1268	TOK	allocated		allocate\VMC----
1269	TOK	irinotecan		irinotecan\JA
1270	TOK	and		and\CC
1271	TOK	supportive		supportive\JA
1272	TOK	care		care\N5S
1273	TOK	and		and\CC
##	TAG	<num>
1274	TOK	90		90\X
##	TAG	</num>
1275	TOK	patients		patient\N5P
1276	TOK	were		be\V6F-A66
1277	TOK	allocated		allocate\VMC----
1278	TOK	supportive		supportive\JA
1279	TOK	care		care\N5S
1280	TOK	alone		alone\DGA7
---	DLE	(		=\DELIM
1281	TOK	figure		figure\N5S
##	TAG	<num>
1282	TOK	1		1\X
##	TAG	</num>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1284	TOK	The	BOS	the\AT---6
1285	TOK	patients		patient\N5P
---	DLD	'		=\DELIM
1286	TOK	characteristics		characteristic\N5P
1287	TOK	are		be\V6FDR66
1288	TOK	shown		show\VMC----
1289	TOK	in		in\P
1290	TOK	table		table\VMI----
##	TAG	<num>
1291	TOK	1		1\X
##	TAG	</num>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1292	TOK	These	BOS	this\AD---P
1293	TOK	characteristics		characteristic\N5P
1294	TOK	were		be\V6F-A66
1295	TOK	similar		similar\JA
1296	TOK	for		for\P
1297	TOK	both		both\RIP3N-
1298	TOK	groups		group\N5P
##	TAG	<loc pos="P">
1299	TOK	except for		except_for\P
##	TAG	</loc>
1300	TOK	performance		performance\N5S
1301	TOK	status		status\N5S
---	DLE	(		=\DELIM
1302	TOK	more		many\JC
1303	TOK	patients		patient\N5P
1304	TOK	having		have\VMG----
1305	TOK	poor		poor\JA
1306	TOK	performance		performance\N5S
1307	TOK	status		status\N5S
1308	TOK	in		in\P
1309	TOK	the		the\AT---6
1310	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
1311	TOK	care		care\N5S
1312	TOK	group		group\VMF6R66
---	DLD	)		=\DELIM
1313	TOK	and		and\CC
1314	TOK	anaemia		anaemia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1315	TOK	Only	BOS	only\DGA7
##	TAG	<num>
1316	TOK	27		27\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1317	TOK	14		14\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1318	TOK	of		of\P
1319	TOK	patients		patient\N5P
1320	TOK	in		in\P
1321	TOK	the		the\AT---6
1322	TOK	irinotecan		irinotecan\JA
1323	TOK	group		group\N5S
1324	TOK	and		and\CC
##	TAG	<num>
1325	TOK	nine		nine\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1326	TOK	10		10\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1327	TOK	in		in\P
1328	TOK	the		the\AT---6
1329	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
1330	TOK	care		care\N5S
1331	TOK	group		group\N5S
1332	TOK	were		be\V6F-A66
1333	TOK	assessed		assess\VMC----
1334	TOK	by		by\P
1335	TOK	carcinoembryonic		carcinoembryonic\JA
1336	TOK	antigen		antigen\N5S
1337	TOK	only		only\DGA7
---	DLD	,		=\DELIM
1338	TOK	with		with\P
1339	TOK	mean		mean\JA
1340	TOK	antigen		antigen\N5S
1341	TOK	ratios		ratio\N5P
##	TAG	<foreign lang="LA" pos="P">
1342	TOK	versus		versus\P
##	TAG	</foreign>
1343	TOK	reference		reference\N5S
1344	TOK	values		value\N5P
1345	TOK	of		of\P
##	TAG	<na type="function">
1346	TOK	2·24		noanat\W
##	TAG	</na>
1347	TOK	and		and\CC
##	TAG	<na type="function">
1348	TOK	2·83		noanat\W
##	TAG	</na>
---	DLE	,		=\DELIM
1349	TOK	respectively		respectively\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<num>
1350	TOK	Six	BOS	Six\X
##	TAG	</num>
1351	TOK	patients		patient\N5P
1352	TOK	in		in\P
1353	TOK	the		the\AT---6
1354	TOK	irinotecan		irinotecan\JA
1355	TOK	group		group\N5S
1356	TOK	did		do\V6FDA66
1357	TOK	not		not\DGA7
1358	TOK	receive		receive\VMI----
1359	TOK	irinotecan		irinotecan\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
1360	TOK	Irinotecan	BOS	Irinotecan\N46
##	TAG	</name>
1361	TOK	was		be\V6F-A66
1362	TOK	given		give\VMC----
1363	TOK	for		for\P
1364	TOK	a		a\AI---S
1365	TOK	median		median\N5S
1366	TOK	of		of\P
##	TAG	<na type="function">
1367	TOK	4·1		noanat\W
##	TAG	</na>
---	DLE	(		=\DELIM
##	TAG	<na type="function">
1368	TOK	0·7-12·6		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
1369	TOK	months		month\N5P
1370	TOK	and		and\CC
##	TAG	<num>
1371	TOK	172		172\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1372	TOK	91		91\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1373	TOK	patients		patient\N5P
1374	TOK	received		receive\VMF6A66
1375	TOK	their		their\APP3N6
1376	TOK	first		first\MOS
1377	TOK	infusion		infusion\N5S
1378	TOK	within		within\P
##	TAG	<num>
1379	TOK	8		8\X
##	TAG	</num>
1380	TOK	days		day\N5P
1381	TOK	of		of\P
1382	TOK	randomisation		randomisation\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<num>
1383	TOK	40	BOS	40\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1384	TOK	21		21\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1385	TOK	patients		patient\N5P
1386	TOK	in		in\P
1387	TOK	the		the\AT---6
1388	TOK	irinotecan		irinotecan\JA
1389	TOK	group		group\N5S
1390	TOK	received		receive\VMF6A66
1391	TOK	subsequent		subsequent\JA
1392	TOK	anticancer		anticancer\JA
1393	TOK	chemotherapies		chemotherapy\N5P
---	DLE	(		=\DELIM
##	TAG	<num>
1394	TOK	31		31\X
##	TAG	</num>
1395	TOK	a		a\AI---S
1396	TOK	fluorouracil		fluorouracil\N5S
1397	TOK	regimen		regimen\N5S
---	DLD	,		=\DELIM
##	TAG	<num>
1398	TOK	nine		nine\X
##	TAG	</num>
1399	TOK	a		a\AI---S
1400	TOK	drug		drug\N5S
1401	TOK	other		other\JA
1402	TOK	than		than\CS
1403	TOK	irinotecan		irinotecan\JA
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1404	TOK	In	BOS	in\P
1405	TOK	the		the\AT---6
1406	TOK	supportive		supportive\JA
1407	TOK	care		care\N5S
1408	TOK	group		group\VMF6R66
##	TAG	<num>
1409	TOK	28		28\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1410	TOK	31		31\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1411	TOK	of		of\P
1412	TOK	patients		patient\N5P
1413	TOK	received		receive\VMC----
1414	TOK	chemotherapy		chemotherapy\N5S
---	DLE	(		=\DELIM
##	TAG	<num>
1415	TOK	21		21\X
##	TAG	</num>
1416	TOK	a		a\AI---S
1417	TOK	fluorouracil		fluorouracil\N5S
1418	TOK	regimen		regimen\N5S
---	DLD	,		=\DELIM
##	TAG	<num>
1419	TOK	nine		nine\X
##	TAG	</num>
1420	TOK	other		other\JA
1421	TOK	drugs		drug\N5P
---	DLD	,		=\DELIM
1422	TOK	and		and\CC
1423	TOK	one		one\RIS3N-
1424	TOK	irinotecan		irinotecan\JA
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<num>
1425	TOK	17	BOS	17\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1426	TOK	19		19\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1427	TOK	patients		patient\N5P
1428	TOK	in		in\P
1429	TOK	the		the\AT---6
1430	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
1431	TOK	care		care\N5S
1432	TOK	group		group\N5S
1433	TOK	received		receive\VMF6A66
1434	TOK	chemotherapy		chemotherapy\N5S
1435	TOK	within		within\P
##	TAG	<num>
1436	TOK	1		1\X
##	TAG	</num>
1437	TOK	month		month\N5S
1438	TOK	of		of\P
1439	TOK	randomisation		randomisation\N5S
1440	TOK	compared		compare\VMC----
1441	TOK	with		with\P
##	TAG	<num>
1442	TOK	two		two\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1443	TOK	1		1\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1444	TOK	in		in\P
1445	TOK	the		the\AT---6
1446	TOK	irinotecan		irinotecan\JA
1447	TOK	group		group\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1448	TOK	Concomitant	BOS	concomitant\JA
1449	TOK	medications		medication\N5P
1450	TOK	at		at\P
1451	TOK	baseline		baseline\N5S
1452	TOK	were		be\V6F-A66
1453	TOK	similar		similar\JA
1454	TOK	in		in\P
1455	TOK	both		both\RIP3N-
1456	TOK	groups		group\N5P
1457	TOK	and		and\CC
1458	TOK	consisted		consist\VMF6A66
1459	TOK	mainly		mainly\DGA7
1460	TOK	of		of\P
1461	TOK	analgesics		analgesic\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
1462	TOK	Overall	BOS	overall\JA
1463	TOK	survival	EOS	survival\N5S
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
1465	TOK	Kaplan-Meier	BOS	Kaplan-Meier\N46
##	TAG	</name>
1466	TOK	estimates		estimate\N5P
1467	TOK	of		of\P
1468	TOK	survival		survival\N5S
1469	TOK	are		be\V6FDR66
1470	TOK	presented		present\VMC----
1471	TOK	in		in\P
1472	TOK	figure		figure\VMI----
##	TAG	<num>
1473	TOK	2		2\X
##	TAG	</num>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1474	TOK	There	BOS	there\DGA7
1475	TOK	were		be\V6F-A66
##	TAG	<num>
1476	TOK	123		123\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1477	TOK	65		65\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1478	TOK	events		event\N5P
1479	TOK	in		in\P
1480	TOK	the		the\AT---6
1481	TOK	irinotecan		irinotecan\JA
1482	TOK	group		group\N5S
---	DLD	,		=\DELIM
1483	TOK	median		median\N5S
1484	TOK	duration		duration\N5S
1485	TOK	of		of\P
1486	TOK	which		which\RW63N-
1487	TOK	was		be\V6F-A66
##	TAG	<na type="function">
1488	TOK	9·2		noanat\W
##	TAG	</na>
---	DLE	(		=\DELIM
1489	TOK	range		range\N5S
##	TAG	<na type="function">
1490	TOK	0- 18·9		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
1491	TOK	months		month\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1492	TOK	The	BOS	the\AT---6
1493	TOK	survival		survival\N5S
1494	TOK	probability		probability\N5S
1495	TOK	for		for\P
1496	TOK	this		this\AD---S
1497	TOK	group		group\N5S
1498	TOK	at		at\P
##	TAG	<num>
1499	TOK	6		6\X
##	TAG	</num>
1500	TOK	months		month\N5P
1501	TOK	was		be\V6F-A66
##	TAG	<num>
1502	TOK	72		72\X
##	TAG	</num>
1503	TOK	·		·\N5P
##	TAG	<num>
1504	TOK	2		2\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
1505	TOK	at		at\P
##	TAG	<num>
1506	TOK	9		9\X
##	TAG	</num>
1507	TOK	months		month\N5P
##	TAG	<num>
1508	TOK	52		52\X
##	TAG	</num>
1509	TOK	·		·\N5P
##	TAG	<num>
1510	TOK	6		6\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
1511	TOK	and		and\CC
1512	TOK	at		at\P
##	TAG	<num>
1513	TOK	12		12\X
##	TAG	</num>
1514	TOK	months		month\N5P
##	TAG	<num>
1515	TOK	36		36\X
##	TAG	</num>
1516	TOK	·		·\N5P
##	TAG	<num>
1517	TOK	2		2\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1518	TOK	In	BOS	in\P
1519	TOK	the		the\AT---6
1520	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
1521	TOK	care		care\N5S
1522	TOK	group		group\N5S
1523	TOK	there		there\DGA7
1524	TOK	were		be\V6F-A66
##	TAG	<num>
1525	TOK	71		71\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1526	TOK	79		79\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1527	TOK	events		event\N5P
---	DLD	,		=\DELIM
1528	TOK	the		the\AT---6
1529	TOK	median		median\N5S
1530	TOK	duration		duration\N5S
1531	TOK	of		of\P
1532	TOK	which		which\RW63N-
1533	TOK	was		be\V6F-A66
##	TAG	<na type="function">
1534	TOK	6·5		noanat\W
##	TAG	</na>
---	DLE	(		=\DELIM
1535	TOK	range		range\N5S
##	TAG	<na type="function">
1536	TOK	0·7-19·3		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
1537	TOK	months		month\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1538	TOK	In	BOS	in\P
1539	TOK	this		this\AD---S
1540	TOK	group		group\N5S
1541	TOK	the		the\AT---6
1542	TOK	survival		survival\N5S
1543	TOK	probability		probability\N5S
1544	TOK	at		at\P
##	TAG	<num>
1545	TOK	6		6\X
##	TAG	</num>
1546	TOK	months		month\N5P
1547	TOK	was		be\V6F-A66
##	TAG	<num>
1548	TOK	54		54\X
##	TAG	</num>
1549	TOK	·		·\N5P
##	TAG	<num>
1550	TOK	1		1\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
1551	TOK	at		at\P
##	TAG	<num>
1552	TOK	9		9\X
##	TAG	</num>
1553	TOK	months		month\N5P
##	TAG	<num>
1554	TOK	29		29\X
##	TAG	</num>
1555	TOK	·		·\N5P
##	TAG	<num>
1556	TOK	1		1\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
1557	TOK	and		and\CC
1558	TOK	at		at\P
##	TAG	<num>
1559	TOK	12		12\X
##	TAG	</num>
1560	TOK	months		month\N5P
##	TAG	<num>
1561	TOK	13		13\X
##	TAG	</num>
1562	TOK	·		·\N5P
##	TAG	<num>
1563	TOK	8		8\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1564	TOK	Median	BOS	median\N5S
1565	TOK	follow		follow\VMF6R66
---	DLI	-		=\DELIM
1566	TOK	up		up\N5S
1567	TOK	was		be\V6F-A66
##	TAG	<na type="function">
1568	TOK	12·9		noanat\W
##	TAG	</na>
1569	TOK	months		month\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1570	TOK	Patients	BOS	patient\N5P
1571	TOK	in		in\P
1572	TOK	the		the\AT---6
1573	TOK	irinotecan		irinotecan\JA
1574	TOK	group		group\N5S
1575	TOK	lived		live\VMF6A66
1576	TOK	significantly		significantly\DGA7
1577	TOK	longer		long\JC
1578	TOK	than		than\CS
1579	TOK	those		that\RDP3N-
1580	TOK	in		in\P
1581	TOK	the		the\AT---6
1582	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
1583	TOK	care		care\N5S
1584	TOK	group		group\VMF6R66
---	DLE	(		=\DELIM
##	TAG	<na type="equation">
1585	TOK	p=0·0001		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1587	TOK	This	BOS	this\AD---S
1588	TOK	benefit		benefit\N5S
1589	TOK	appeared		appear\VMF6A66
1590	TOK	after		after\P
##	TAG	<num>
1591	TOK	2		2\X
##	TAG	</num>
1592	TOK	months		month\N5P
1593	TOK	and		and\CC
1594	TOK	became		become\VMF6A66
1595	TOK	more		more\DDC7
1596	TOK	apparent		apparent\JA
1597	TOK	throughout		throughout\P
1598	TOK	the		the\AT---6
1599	TOK	study		study\N5S
1600	TOK	period		period\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<num>
1601	TOK	1	BOS	1\X
##	TAG	</num>
---	DLE	-		=\DELIM
1602	TOK	year		year\N5S
1603	TOK	survival		survival\N5S
1604	TOK	was		be\V6F-A66
##	TAG	<num>
1605	TOK	36		36\X
##	TAG	</num>
1606	TOK	·		·\N5P
##	TAG	<num>
1607	TOK	2		2\X
##	TAG	</num>
---	DLD	%		=\DELIM
1608	TOK	and		and\CC
##	TAG	<na type="function">
1609	TOK	13·8% in		noanat\W
##	TAG	</na>
1610	TOK	the		the\AT---6
1611	TOK	irinotecan		irinotecan\JA
1612	TOK	and		and\CC
1613	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
1614	TOK	care		care\N5S
1615	TOK	groups		group\N5P
---	DLD	,		=\DELIM
1616	TOK	respectively		respectively\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1617	TOK	Median	BOS	median\N5S
1618	TOK	survival		survival\N5S
1619	TOK	was		be\V6F-A66
##	TAG	<na type="function">
1620	TOK	9·2		noanat\W
##	TAG	</na>
1621	TOK	and		and\CC
##	TAG	<na type="function">
1622	TOK	6·5		noanat\W
##	TAG	</na>
1623	TOK	months		month\N5P
---	DLD	,		=\DELIM
1624	TOK	respectively		respectively\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1625	TOK	A	BOS	a\AI---S
1626	TOK	univariate		univariate\JA
##	TAG	<name>
1627	TOK	Cox		Cox\N46
##	TAG	</name>
1628	PGR	's		genmark\GENMARK
1629	TOK	model		model\N5S
1630	TOK	showed		show\VMF6A66
1631	TOK	that		that\CS
1632	TOK	patients		patient\N5P
1633	TOK	with		with\P
1634	TOK	performance		performance\N5S
1635	TOK	status		status\N5S
##	TAG	<num>
1636	TOK	0		0\X
##	TAG	</num>
1637	TOK	or		or\CC
##	TAG	<num>
1638	TOK	1		1\X
##	TAG	</num>
1639	TOK	shared		share\VMF6A66
1640	TOK	the		the\AT---6
1641	TOK	same		same\JA
1642	TOK	prognosis		prognosis\N5S
---	DLD	,		=\DELIM
1643	TOK	which		which\RW63N-
1644	TOK	was		be\V6F-A66
1645	TOK	notably		notably\DGA7
1646	TOK	better		good\JC
1647	TOK	than		than\CS
1648	TOK	that		that\RDS3N-
1649	TOK	for		for\P
1650	TOK	patients		patient\N5P
1651	TOK	with		with\P
1652	TOK	performance		performance\N5S
1653	TOK	status		status\N5S
##	TAG	<num>
1654	TOK	2		2\X
##	TAG	</num>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1655	TOK	Figure	BOS	figure\N5S
##	TAG	<num>
1656	TOK	3		3\X
##	TAG	</num>
1657	TOK	shows		show\VMFDRS3
1658	TOK	that		that\CS
1659	TOK	the		the\AT---6
1660	TOK	benefit		benefit\N5S
1661	TOK	of		of\P
1662	TOK	treatment		treatment\N5S
1663	TOK	occurred		occur\VMF6A66
1664	TOK	in		in\P
1665	TOK	all		all\AG---6
1666	TOK	performance		performance\N5S
---	DLI	-		=\DELIM
1667	TOK	status		status\N5S
1668	TOK	groups		group\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1669	TOK	With	BOS	with\P
1670	TOK	a		a\AI---S
1671	TOK	performance		performance\N5S
1672	TOK	status		status\N5S
1673	TOK	of		of\P
1674	TOK	less		less\DDC7
1675	TOK	than		than\CS
##	TAG	<num>
1676	TOK	two		two\X
##	TAG	</num>
1677	TOK	there		there\DGA7
1678	TOK	were		be\V6F-A66
##	TAG	<num>
1679	TOK	98		98\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1680	TOK	60		60\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1681	TOK	events		event\N5P
1682	TOK	in		in\P
1683	TOK	the		the\AT---6
1684	TOK	irinotecan		irinotecan\JA
1685	TOK	group		group\N5S
---	DLD	,		=\DELIM
1686	TOK	median		median\N5S
1687	TOK	duration		duration\N5S
1688	TOK	of		of\P
1689	TOK	which		which\RW63N-
1690	TOK	was		be\V6F-A66
##	TAG	<na type="function">
1691	TOK	10·5		noanat\W
##	TAG	</na>
---	DLE	(		=\DELIM
1692	TOK	range		range\N5S
##	TAG	<na type="function">
1693	TOK	0-18·9		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
1694	TOK	months		month\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1695	TOK	The	BOS	the\AT---6
1696	TOK	survival		survival\N5S
1697	TOK	probability		probability\N5S
1698	TOK	for		for\P
1699	TOK	this		this\AD---S
1700	TOK	group		group\N5S
1701	TOK	at		at\P
##	TAG	<num>
1702	TOK	6		6\X
##	TAG	</num>
1703	TOK	months		month\N5P
1704	TOK	was		be\V6F-A66
##	TAG	<num>
1705	TOK	76		76\X
##	TAG	</num>
1706	TOK	·		·\N5P
##	TAG	<num>
1707	TOK	3		3\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
1708	TOK	at		at\P
##	TAG	<num>
1709	TOK	9		9\X
##	TAG	</num>
1710	TOK	months		month\N5P
##	TAG	<num>
1711	TOK	57		57\X
##	TAG	</num>
1712	TOK	·		·\N5P
##	TAG	<num>
1713	TOK	2		2\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
1714	TOK	and		and\CC
1715	TOK	at		at\P
##	TAG	<num>
1716	TOK	12		12\X
##	TAG	</num>
1717	TOK	months		month\N5P
##	TAG	<num>
1718	TOK	40		40\X
##	TAG	</num>
1719	TOK	·		·\N5P
##	TAG	<num>
1720	TOK	1		1\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1721	TOK	In	BOS	in\P
1722	TOK	the		the\AT---6
1723	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
1724	TOK	care		care\N5S
---	DLI	-		=\DELIM
1725	TOK	alone		alone\JA
1726	TOK	group		group\N5S
1727	TOK	there		there\DGA7
1728	TOK	were		be\V6F-A66
##	TAG	<num>
1729	TOK	53		53\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1730	TOK	77		77\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1731	TOK	events		event\N5P
---	DLD	,		=\DELIM
1732	TOK	median		median\N5S
1733	TOK	duration		duration\N5S
##	TAG	<na type="function">
1734	TOK	7·4		noanat\W
##	TAG	</na>
---	DLE	(		=\DELIM
##	TAG	<na type="function">
1735	TOK	0·7-19·3		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
1736	TOK	months		month\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1737	TOK	In	BOS	in\P
1738	TOK	this		this\AD---S
1739	TOK	group		group\N5S
1740	TOK	the		the\AT---6
1741	TOK	survival		survival\N5S
1742	TOK	probability		probability\N5S
1743	TOK	at		at\P
##	TAG	<num>
1744	TOK	6		6\X
##	TAG	</num>
1745	TOK	months		month\N5P
1746	TOK	was		be\V6F-A66
##	TAG	<num>
1747	TOK	62		62\X
##	TAG	</num>
1748	TOK	·		·\N5P
##	TAG	<num>
1749	TOK	5		5\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
1750	TOK	at		at\P
##	TAG	<num>
1751	TOK	9		9\X
##	TAG	</num>
1752	TOK	months		month\N5P
##	TAG	<num>
1753	TOK	33		33\X
##	TAG	</num>
1754	TOK	·		·\N5P
##	TAG	<num>
1755	TOK	2		2\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
1756	TOK	and		and\CC
1757	TOK	at		at\P
##	TAG	<num>
1758	TOK	12		12\X
##	TAG	</num>
1759	TOK	months		month\N5P
##	TAG	<num>
1760	TOK	16		16\X
##	TAG	</num>
1761	TOK	·		·\N5P
##	TAG	<num>
1762	TOK	2		2\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1763	TOK	With	BOS	with\P
1764	TOK	a		a\AI---S
1765	TOK	performance		performance\N5S
1766	TOK	status		status\N5S
1767	TOK	of		of\P
##	TAG	<num>
1768	TOK	two		two\X
##	TAG	</num>
1769	TOK	there		there\DGA7
1770	TOK	were		be\V6F-A66
##	TAG	<num>
1771	TOK	24		24\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1772	TOK	92		92\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1773	TOK	events		event\N5P
1774	TOK	in		in\P
1775	TOK	the		the\AT---6
1776	TOK	irinotecan		irinotecan\JA
1777	TOK	group		group\N5S
---	DLD	,		=\DELIM
1778	TOK	median		median\N5S
1779	TOK	duration		duration\N5S
1780	TOK	of		of\P
1781	TOK	which		which\RW63N-
1782	TOK	was		be\V6F-A66
##	TAG	<na type="function">
1783	TOK	5·1		noanat\W
##	TAG	</na>
1784	TOK	range		range\N5S
##	TAG	<na type="function">
1785	TOK	0·3-18·5		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
1786	TOK	months		month\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1787	TOK	The	BOS	the\AT---6
1788	TOK	survival		survival\N5S
1789	TOK	probability		probability\N5S
1790	TOK	for		for\P
1791	TOK	this		this\AD---S
1792	TOK	group		group\N5S
1793	TOK	at		at\P
##	TAG	<num>
1794	TOK	6		6\X
##	TAG	</num>
1795	TOK	months		month\N5P
1796	TOK	was		be\V6F-A66
##	TAG	<num>
1797	TOK	46		46\X
##	TAG	</num>
1798	TOK	·		·\N5P
##	TAG	<num>
1799	TOK	2		2\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
1800	TOK	at		at\P
##	TAG	<num>
1801	TOK	9		9\X
##	TAG	</num>
1802	TOK	months		month\N5P
##	TAG	<num>
1803	TOK	26		26\X
##	TAG	</num>
1804	TOK	·		·\N5P
##	TAG	<num>
1805	TOK	9		9\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
1806	TOK	and		and\CC
1807	TOK	at		at\P
##	TAG	<num>
1808	TOK	12		12\X
##	TAG	</num>
1809	TOK	months		month\N5P
##	TAG	<num>
1810	TOK	15		15\X
##	TAG	</num>
1811	TOK	·		·\N5P
##	TAG	<num>
1812	TOK	4		4\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1813	TOK	In	BOS	in\P
1814	TOK	the		the\AT---6
1815	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
1816	TOK	care		care\N5S
1817	TOK	group		group\N5S
1818	TOK	there		there\DGA7
1819	TOK	were		be\V6F-A66
##	TAG	<num>
1820	TOK	18		18\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1821	TOK	86		86\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1822	TOK	events		event\N5P
---	DLD	,		=\DELIM
1823	TOK	the		the\AT---6
1824	TOK	median		median\N5S
1825	TOK	duration		duration\N5S
1826	TOK	of		of\P
1827	TOK	which		which\RW63N-
1828	TOK	was		be\V6F-A66
##	TAG	<na type="function">
1829	TOK	3·5		noanat\W
##	TAG	</na>
---	DLE	(		=\DELIM
1830	TOK	range		range\N5S
##	TAG	<na type="function">
1831	TOK	1·1-11·0		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
1832	TOK	months		month\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1833	TOK	In	BOS	in\P
1834	TOK	this		this\AD---S
1835	TOK	group		group\N5S
1836	TOK	the		the\AT---6
1837	TOK	survival		survival\N5S
1838	TOK	probability		probability\N5S
1839	TOK	at		at\P
##	TAG	<num>
1840	TOK	6		6\X
##	TAG	</num>
1841	TOK	months		month\N5P
1842	TOK	was		be\V6F-A66
##	TAG	<num>
1843	TOK	26		26\X
##	TAG	</num>
1844	TOK	·		·\N5P
##	TAG	<num>
1845	TOK	5		5\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
1846	TOK	at		at\P
##	TAG	<num>
1847	TOK	9		9\X
##	TAG	</num>
1848	TOK	months		month\N5P
##	TAG	<num>
1849	TOK	15		15\X
##	TAG	</num>
1850	TOK	·		·\N5P
##	TAG	<num>
1851	TOK	9		9\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
1852	TOK	and		and\CC
1853	TOK	at		at\P
##	TAG	<num>
1854	TOK	12		12\X
##	TAG	</num>
1855	TOK	months		month\N5P
##	TAG	<num>
1856	TOK	7		7\X
##	TAG	</num>
1857	TOK	·		·\N5P
##	TAG	<num>
1858	TOK	9		9\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1859	TOK	Multivariate	BOS	multivariate\JA
##	TAG	<name>
1860	TOK	Cox		Cox\N46
##	TAG	</name>
1861	PGR	's		genmark\GENMARK
1862	TOK	regression		regression\N5S
1863	TOK	confirmed		confirm\VMF6A66
1864	TOK	the		the\AT---6
1865	TOK	importance		importance\N5S
1866	TOK	of		of\P
1867	TOK	other		other\JA
1868	TOK	known		know\VMC----
1869	TOK	prognostic		prognostic\JA
1870	TOK	factors		factor\N5P
---	DLE	(		=\DELIM
1871	TOK	table		table\VMF6R66
##	TAG	<num>
1872	TOK	2		2\X
##	TAG	</num>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1874	TOK	When	BOS	when\CS
1875	TOK	the		the\AT---6
1876	TOK	treatment		treatment\N5S
1877	TOK	group		group\N5S
1878	TOK	was		be\V6F-A66
1879	TOK	included		include\VMC----
1880	TOK	in		in\P
1881	TOK	the		the\AT---6
1882	TOK	model		model\N5S
---	DLD	,		=\DELIM
1883	TOK	the		the\AT---6
1884	TOK	survival		survival\N5S
1885	TOK	benefit		benefit\N5S
1886	TOK	for		for\P
1887	TOK	the		the\AT---6
1888	TOK	irinotecan		irinotecan\JA
1889	TOK	group		group\N5S
1890	TOK	remained		remain\VMF6A66
1891	TOK	significant		significant\JA
---	DLE	(		=\DELIM
##	TAG	<na type="equation">
1892	TOK	p=0·001		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
1893	TOK	Secondary	BOS	secondary\JA
1894	TOK	endpoints	EOS	endpoint\N5P
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
1896	TOK	Survival	BOS	survival\N5S
1897	TOK	without		without\P
1898	TOK	weight		weight\N5S
1899	TOK	loss		loss\N5S
1900	TOK	of		of\P
1901	TOK	more		more\DDC7
1902	TOK	than		than\CS
##	TAG	<num>
1903	TOK	5		5\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLE	(		=\DELIM
##	TAG	<na type="equation">
1904	TOK	p=0·018		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
1905	TOK	and		and\CC
1906	TOK	survival		survival\N5S
1907	TOK	without		without\P
1908	TOK	performance		performance\N5S
---	DLI	-		=\DELIM
1909	TOK	status		status\N5S
1910	TOK	deterioration		deterioration\N5S
---	DLE	(		=\DELIM
##	TAG	<na type="equation">
1911	TOK	p=0·0001		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
1912	TOK	were		be\V6F-A66
1913	TOK	significantly		significantly\DGA7
1914	TOK	longer		long\JC
1915	TOK	in		in\P
1916	TOK	the		the\AT---6
1917	TOK	irinotecan		irinotecan\JA
1918	TOK	group		group\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1919	TOK	More	BOS	many\JC
1920	TOK	patients		patient\N5P
1921	TOK	with		with\P
1922	TOK	a		a\AI---S
1923	TOK	performance		performance\N5S
---	DLI	-		=\DELIM
1924	TOK	status		status\N5S
1925	TOK	of		of\P
1926	TOK	worse		bad\JC
1927	TOK	than		than\CS
##	TAG	<num>
1928	TOK	0		0\X
##	TAG	</num>
1929	TOK	at		at\P
1930	TOK	baseline		baseline\N5S
1931	TOK	improved		improve\VMF6A66
1932	TOK	their		their\APP3N6
1933	TOK	performance		performance\N5S
1934	TOK	status		status\N5S
---	DLD	:		=\DELIM
##	TAG	<num>
1935	TOK	35		35\X
##	TAG	</num>
---	DLD	%		=\DELIM
##	TAG	<foreign lang="LA" pos="P">
1936	TOK	versus		versus\P
##	TAG	</foreign>
##	TAG	<num>
1937	TOK	11		11\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLE	(		=\DELIM
##	TAG	<na type="equation">
1938	TOK	p=0·002		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1939	TOK	Pain	BOS	pain\N5S
---	DLI	-		=\DELIM
1940	TOK	free		free\JA
1941	TOK	survival		survival\N5S
1942	TOK	in		in\P
1943	TOK	patients		patient\N5P
1944	TOK	without		without\P
1945	TOK	pain		pain\N5S
1946	TOK	at		at\P
1947	TOK	baseline		baseline\N5S
---	DLE	(		=\DELIM
1948	TOK	figure		figure\N5S
##	TAG	<num>
1949	TOK	4		4\X
##	TAG	</num>
---	DLE	)		=\DELIM
1950	TOK	was		be\V6F-A66
1951	TOK	significantly		significantly\DGA7
1952	TOK	longer		long\JC
1953	TOK	in		in\P
1954	TOK	the		the\AT---6
1955	TOK	irinotecan		irinotecan\JA
1956	TOK	group		group\N5S
1957	TOK	than		than\CS
1958	TOK	in		in\P
1959	TOK	the		the\AT---6
1960	TOK	supportive		supportive\JA
1961	TOK	care		care\N5S
1962	TOK	group		group\VMF6R66
---	DLE	(		=\DELIM
##	TAG	<na type="equation">
1963	TOK	p=0·003		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
1964	TOK	despite		despite\P
1965	TOK	a		a\AI---S
1966	TOK	higher		high\JC
1967	TOK	proportion		proportion\N5S
1968	TOK	of		of\P
1969	TOK	patients		patient\N5P
1970	TOK	on		on\P
1971	TOK	opioids		opioid\N5P
1972	TOK	in		in\P
1973	TOK	the		the\AT---6
1974	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
1975	TOK	care		care\N5S
1976	TOK	group		group\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1977	TOK	There	BOS	there\DGA7
1978	TOK	were		be\V6F-A66
##	TAG	<num>
1979	TOK	61		61\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
1980	TOK	73		73\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
1981	TOK	events		event\N5P
1982	TOK	in		in\P
1983	TOK	the		the\AT---6
1984	TOK	irinotecan		irinotecan\JA
1985	TOK	group		group\N5S
---	DLD	,		=\DELIM
1986	TOK	median		median\N5S
1987	TOK	duration		duration\N5S
1988	TOK	of		of\P
1989	TOK	which		which\RW63N-
1990	TOK	was		be\V6F-A66
##	TAG	<na type="function">
1991	TOK	6·9		noanat\W
##	TAG	</na>
---	DLE	(		=\DELIM
1992	TOK	range		range\N5S
##	TAG	<na type="function">
1993	TOK	0·3-17·2		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
1994	TOK	months		month\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1995	TOK	The	BOS	the\AT---6
1996	TOK	survival		survival\N5S
1997	TOK	probability		probability\N5S
1998	TOK	for		for\P
1999	TOK	this		this\AD---S
2000	TOK	group		group\N5S
2001	TOK	at		at\P
##	TAG	<num>
2002	TOK	6		6\X
##	TAG	</num>
2003	TOK	months		month\N5P
2004	TOK	was		be\V6F-A66
##	TAG	<num>
2005	TOK	56		56\X
##	TAG	</num>
2006	TOK	·		·\N5P
##	TAG	<num>
2007	TOK	8		8\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
2008	TOK	at		at\P
##	TAG	<num>
2009	TOK	9		9\X
##	TAG	</num>
2010	TOK	months		month\N5P
##	TAG	<num>
2011	TOK	36		36\X
##	TAG	</num>
2012	TOK	·		·\N5P
##	TAG	<num>
2013	TOK	6		6\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
2014	TOK	and		and\CC
2015	TOK	at		at\P
##	TAG	<num>
2016	TOK	12		12\X
##	TAG	</num>
2017	TOK	months		month\N5P
##	TAG	<num>
2018	TOK	18		18\X
##	TAG	</num>
2019	TOK	·		·\N5P
##	TAG	<num>
2020	TOK	8		8\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2021	TOK	In	BOS	in\P
2022	TOK	the		the\AT---6
2023	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
2024	TOK	care		care\N5S
2025	TOK	group		group\N5S
2026	TOK	there		there\DGA7
2027	TOK	were		be\V6F-A66
##	TAG	<num>
2028	TOK	26		26\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
2029	TOK	79		79\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
2030	TOK	events		event\N5P
---	DLD	,		=\DELIM
2031	TOK	median		median\N5S
2032	TOK	duration		duration\N5S
##	TAG	<na type="function">
2033	TOK	2·0		noanat\W
##	TAG	</na>
---	DLE	(		=\DELIM
##	TAG	<na type="function">
2034	TOK	0-13·0		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
2035	TOK	months		month\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2036	TOK	In	BOS	in\P
2037	TOK	this		this\AD---S
2038	TOK	group		group\N5S
2039	TOK	the		the\AT---6
2040	TOK	survival		survival\N5S
2041	TOK	probability		probability\N5S
2042	TOK	at		at\P
##	TAG	<num>
2043	TOK	6		6\X
##	TAG	</num>
2044	TOK	months		month\N5P
2045	TOK	was		be\V6F-A66
##	TAG	<num>
2046	TOK	31		31\X
##	TAG	</num>
2047	TOK	·		·\N5P
##	TAG	<num>
2048	TOK	5		5\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
2049	TOK	at		at\P
##	TAG	<num>
2050	TOK	9		9\X
##	TAG	</num>
2051	TOK	months		month\N5P
##	TAG	<num>
2052	TOK	14		14\X
##	TAG	</num>
2053	TOK	·		·\N5P
##	TAG	<num>
2054	TOK	7		7\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	,		=\DELIM
2055	TOK	and		and\CC
2056	TOK	at		at\P
##	TAG	<num>
2057	TOK	12		12\X
##	TAG	</num>
2058	TOK	months		month\N5P
##	TAG	<num>
2059	TOK	4		4\X
##	TAG	</num>
2060	TOK	·		·\N5P
##	TAG	<num>
2061	TOK	9		9\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2062	TOK	Within	BOS	within\P
##	TAG	<num>
2063	TOK	23		23\X
##	TAG	</num>
2064	TOK	weeks		week\N5P
2065	TOK	of		of\P
2066	TOK	randomisation		randomisation\N5P
---	DLD	,		=\DELIM
2067	TOK	the		the\AT---6
2068	TOK	rate		rate\N5S
2069	TOK	of		of\P
2070	TOK	patients		patient\N5P
2071	TOK	with		with\P
2072	TOK	opioid		opioid\N5S
2073	TOK	consumption		consumption\N5S
2074	TOK	by		by\P
##	TAG	<num>
2075	TOK	3		3\X
##	TAG	</num>
---	DLE	-		=\DELIM
2076	TOK	week		week\N5S
2077	TOK	blocks		block\N5P
2078	TOK	ranged		range\VMF6A66
2079	TOK	from		from\P
##	TAG	<na type="function">
2080	TOK	25% to		noanat\W
##	TAG	</na>
##	TAG	<na type="function">
2081	TOK	34% in		noanat\W
##	TAG	</na>
2082	TOK	the		the\AT---6
2083	TOK	irinotecan		irinotecan\JA
2084	TOK	group		group\N5S
2085	TOK	and		and\CC
2086	TOK	from		from\P
##	TAG	<na type="function">
2087	TOK	40% to		noanat\W
##	TAG	</na>
##	TAG	<na type="function">
2088	TOK	56% in		noanat\W
##	TAG	</na>
2089	TOK	the		the\AT---6
2090	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
2091	TOK	care		care\N5S
2092	TOK	group		group\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2093	TOK	In	BOS	in\P
2094	TOK	the		the\AT---6
2095	TOK	quality		quality\N5S
---	DLI	-		=\DELIM
2096	TOK	of		of\P
---	DLI	-		=\DELIM
2097	TOK	life		life\N5S
2098	TOK	analysis		analysis\N5S
---	DLD	,		=\DELIM
2099	TOK	compliance		compliance\N5S
2100	TOK	of		of\P
2101	TOK	patients		patient\N5P
2102	TOK	was		be\V6F-A66
2103	TOK	about		about\P
##	TAG	<na type="function">
2104	TOK	80% in		noanat\W
##	TAG	</na>
2105	TOK	both		both\RIP3N-
2106	TOK	groups		group\N5P
2107	TOK	at		at\P
2108	TOK	the		the\AT---6
2109	TOK	beginning		beginning\N5S
2110	TOK	of		of\P
2111	TOK	study		study\N5S
2112	TOK	and		and\CC
2113	TOK	decreased		decrease\VMC----
2114	TOK	during		during\P
2115	TOK	the		the\AT---6
2116	TOK	study		study\N5S
2117	TOK	to		to\P
2118	TOK	about		about\DGA7
##	TAG	<num>
2119	TOK	50		50\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2120	TOK	Compliance	BOS	compliance\N5S
2121	TOK	decreased		decrease\VMF6A66
2122	TOK	more		more\DDC7
2123	TOK	rapidly		rapidly\DGA7
2124	TOK	in		in\P
2125	TOK	the		the\AT---6
2126	TOK	supportive		supportive\JA
2127	TOK	care		care\N5S
2128	TOK	group		group\VMF6R66
---	DLD	,		=\DELIM
2129	TOK	probably		probably\DGA7
2130	TOK	due		due\JA
2131	TOK	to		to\P
2132	TOK	earlier		early\JC
2133	TOK	deterioration		deterioration\N5S
2134	TOK	in		in\P
2135	TOK	the		the\AT---6
2136	TOK	patients		patient\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2137	TOK	On	BOS	on\P
2138	TOK	difference		difference\N5S
2139	TOK	from		from\P
2140	TOK	baseline		baseline\N5S
2141	TOK	multivariate		multivariate\JA
2142	TOK	analysis		analysis\N5S
2143	TOK	of		of\P
2144	TOK	variance		variance\N5S
2145	TOK	was		be\V6F-A66
2146	TOK	significant		significant\JA
---	DLE	(		=\DELIM
##	TAG	<na type="equation">
2147	TOK	p=0·0001		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2149	TOK	The	BOS	the\AT---6
2150	TOK	univariate		univariate\JA
2151	TOK	analyses		analysis\N5P
2152	TOK	of		of\P
2153	TOK	variance		variance\N5S
2154	TOK	were		be\V6F-A66
2155	TOK	significantly		significantly\DGA7
2156	TOK	in		in\P
2157	TOK	favour		favour\N5S
2158	TOK	of		of\P
2159	TOK	the		the\AT---6
2160	TOK	irinotecan		irinotecan\JA
2161	TOK	group		group\N5S
2162	TOK	for		for\P
2163	TOK	the		the\AT---6
2164	TOK	cognitive		cognitive\JA
2165	TOK	functioning		function\VMG----
2166	TOK	score		score\N56
---	DLE	(		=\DELIM
2167	TOK	xxx		noanat\W
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
2168	TOK	the		the\AT---6
2169	TOK	global		global\JA
2170	TOK	quality		quality\N5S
---	DLI	-		=\DELIM
2171	TOK	of		of\P
---	DLI	-		=\DELIM
2172	TOK	life		life\N5S
2173	TOK	score		score\N56
---	DLE	(		=\DELIM
2174	TOK	xxx		noanat\W
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
2175	TOK	the		the\AT---6
2176	TOK	pain		pain\N5S
2177	TOK	score		score\N56
---	DLE	(		=\DELIM
2178	TOK	xxx		noanat\W
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
2179	TOK	dyspnoea		dyspnoea\N5S
---	DLE	(		=\DELIM
2180	TOK	xxx		noanat\W
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
2181	TOK	appetite		appetite\N5S
2182	TOK	loss		loss\N5S
---	DLE	(		=\DELIM
2183	TOK	xxx		noanat\W
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
2184	TOK	and		and\CC
2185	TOK	financial		financial\JA
---	DLI	-		=\DELIM
2186	TOK	impact		impact\N5S
2187	TOK	scores		score\N5P
---	DLE	(		=\DELIM
2188	TOK	xxx		noanat\W
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2190	TOK	The	BOS	the\AT---6
2191	TOK	diarrhoea		diarrhoea\N5S
2192	TOK	score		score\N56
2193	TOK	was		be\V6F-A66
2194	TOK	significantly		significantly\DGA7
2195	TOK	better		good\JC
2196	TOK	in		in\P
2197	TOK	the		the\AT---6
2198	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
2199	TOK	care		care\N5S
2200	TOK	group		group\VMF6R66
---	DLE	(		=\DELIM
2201	TOK	xxx		noanat\W
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2203	TOK	Analyses	BOS	analysis\N5P
2204	TOK	on		on\P
2205	TOK	worst		bad\JS
2206	TOK	patient		patient\N5S
2207	TOK	score		score\N56
2208	TOK	during		during\P
2209	TOK	the		the\AT---6
2210	TOK	study		study\N5S
2211	TOK	are		be\V6FDR66
2212	TOK	shown		show\VMC----
2213	TOK	in		in\P
2214	TOK	table		table\VMI----
##	TAG	<num>
2215	TOK	3		3\X
##	TAG	</num>
---	DLD	:		=\DELIM
2216	TOK	all		all\AG---6
2217	TOK	results		result\N5P
2218	TOK	were		be\V6F-A66
2219	TOK	significantly		significantly\DGA7
2220	TOK	in		in\P
2221	TOK	favour		favour\N5S
2222	TOK	of		of\P
2223	TOK	irinotecan		irinotecan\N5S
##	TAG	<loc pos="P">
2224	TOK	except for		except_for\P
##	TAG	</loc>
2225	TOK	emotional		emotional\JA
---	DLD	,		=\DELIM
2226	TOK	nausea		nausea\N5S
---	DLD	,		=\DELIM
2227	TOK	sleep		sleep\N5S
2228	TOK	disturbance		disturbance\N5S
---	DLD	,		=\DELIM
2229	TOK	and		and\CC
2230	TOK	financial		financial\JA
2231	TOK	scores		score\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2232	TOK	Diarrhoea	BOS	diarrhoea\N5S
2233	TOK	score		score\N56
2234	TOK	was		be\V6F-A66
2235	TOK	significantly		significantly\DGA7
2236	TOK	lower		low\JC
2237	TOK	in		in\P
2238	TOK	the		the\AT---6
2239	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
2240	TOK	care		care\N5S
2241	TOK	group		group\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2242	TOK	Time	BOS	time\N5S
2243	TOK	to		to\P
2244	TOK	definitive		definitive\JA
2245	TOK	quality		quality\N5S
---	DLI	-		=\DELIM
2246	TOK	of		of\P
---	DLI	-		=\DELIM
2247	TOK	life		life\N5S
2248	TOK	deterioration		deterioration\N5S
2249	TOK	was		be\V6F-A66
2250	TOK	significantly		significantly\DGA7
2251	TOK	longer		long\JC
2252	TOK	in		in\P
2253	TOK	the		the\AT---6
2254	TOK	irinotecan		irinotecan\JA
2255	TOK	group		group\N5S
---	DLD	,		=\DELIM
2256	TOK	whichever		whichever\JA
2257	TOK	the		the\AT---6
2258	TOK	chosen		choose\VMC----
2259	TOK	threshold		threshold\N5S
2260	TOK	for		for\P
2261	TOK	deterioration		deterioration\N5S
---	DLE	(		=\DELIM
2262	TOK	all		all\AG---6
2263	TOK	p		p\N5S
2264	TOK	values		value\N5P
2265	TOK	xxx		noanat\W
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
2266	TOK	Safety	BOS	safety\N5S
tf	TOK		EOS	=\DELS
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
2268	TOK	Table	BOS	table\VMF6R66
##	TAG	<num>
2269	TOK	4		4\X
##	TAG	</num>
2270	TOK	shows		show\VMFDRS3
2271	TOK	the		the\AT---6
2272	TOK	incidence		incidence\N5S
2273	TOK	of		of\P
2274	TOK	grade		grade\VMI----
##	TAG	<num>
2275	TOK	3		3\X
##	TAG	</num>
2276	TOK	or		or\CC
##	TAG	<num>
2277	TOK	4		4\X
##	TAG	</num>
2278	TOK	adverse		adverse\JA
2279	TOK	events		event\N5P
---	DLE	(		=\DELIM
2280	TOK	drug		drug\N5S
2281	TOK	related		relate\VMC----
2282	TOK	or		or\CC
2283	TOK	not		not\DGA7
---	DLD	)		=\DELIM
2284	TOK	by		by\P
2285	TOK	patient		patient\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2286	TOK	Patients	BOS	patient\N5P
2287	TOK	on		on\P
2288	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
2289	TOK	care		care\N5S
2290	TOK	alone		alone\DGA7
2291	TOK	experienced		experience\VMF6A66
2292	TOK	a		a\AI---S
2293	TOK	high		high\JA
2294	TOK	incidence		incidence\N5S
2295	TOK	of		of\P
2296	TOK	severe		severe\JA
2297	TOK	adverse		adverse\JA
2298	TOK	events		event\N5P
---	DLD	,		=\DELIM
2299	TOK	especially		especially\DGA7
2300	TOK	pain		pain\N5S
2301	TOK	and		and\CC
2302	TOK	asthenia		asthenia\N5S
---	DLD	,		=\DELIM
2303	TOK	although		although\CS
2304	TOK	significantly		significantly\DGA7
2305	TOK	more		many\JC
2306	TOK	patients		patient\N5P
2307	TOK	in		in\P
2308	TOK	the		the\AT---6
2309	TOK	irinotecan		irinotecan\JA
2310	TOK	group		group\N5S
2311	TOK	experienced		experience\VMF6A66
2312	TOK	severe		severe\JA
2313	TOK	events		event\N5P
---	DLD	,		=\DELIM
2314	TOK	especially		especially\DGA7
2315	TOK	neutropenia		neutropenia\N5S
---	DLD	,		=\DELIM
2316	TOK	nausea		nausea\N5S
---	DLD	,		=\DELIM
2317	TOK	vomiting		vomit\VMG----
---	DLD	,		=\DELIM
2318	TOK	and		and\CC
2319	TOK	diarrhoea		diarrhoea\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<num>
2320	TOK	Two	BOS	Two\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
2321	TOK	1		1\X
##	TAG	</num>
2322	TOK	·		·\N5P
##	TAG	<num>
2323	TOK	1		1\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
2324	TOK	of		of\P
##	TAG	<num>
2325	TOK	183		183\X
##	TAG	</num>
2326	TOK	patients		patient\N5P
2327	TOK	treated		treat\VMC----
2328	TOK	with		with\P
2329	TOK	irinotecan		irinotecan\N5S
2330	TOK	died		die\VMF6A66
2331	TOK	of		of\P
2332	TOK	drug		drug\N5S
---	DLI	-		=\DELIM
2333	TOK	related		relate\VMC----
2334	TOK	causes		cause\N5P
2335	TOK	although		although\CS
---	DLD	,		=\DELIM
2336	TOK	in		in\P
2337	TOK	one		one\MCS
---	DLD	,		=\DELIM
2338	TOK	the		the\AT---6
2339	TOK	association		association\N5S
2340	TOK	with		with\P
2341	TOK	adverse		adverse\JA
2342	TOK	events		event\N5P
---	DLE	(		=\DELIM
2343	TOK	diarrhoea		diarrhoea\N5S
2344	TOK	and/or		and/or\N5S
2345	TOK	febrile		febrile\JA
2346	TOK	neutropenia		neutropenia\N5S
---	DLD	)		=\DELIM
2347	TOK	has		have\V6FDRS3
2348	TOK	not		not\DGA7
2349	TOK	been		be\VMC----
2350	TOK	clearly		clearly\DGA7
2351	TOK	established		establish\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2352	TOK	Admission	BOS	admission\N5S
2353	TOK	for		for\P
2354	TOK	adverse		adverse\JA
2355	TOK	events		event\N5P
2356	TOK	occurred		occur\VMF6A66
2357	TOK	in		in\P
##	TAG	<num>
2358	TOK	136		136\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
2359	TOK	72		72\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
2360	TOK	of		of\P
2361	TOK	patients		patient\N5P
2362	TOK	in		in\P
2363	TOK	the		the\AT---6
2364	TOK	irinotecan		irinotecan\JA
2365	TOK	group		group\N5S
2366	TOK	and		and\CC
##	TAG	<num>
2367	TOK	57		57\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<num>
2368	TOK	63		63\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
2369	TOK	of		of\P
2370	TOK	patients		patient\N5P
2371	TOK	in		in\P
2372	TOK	the		the\AT---6
2373	TOK	supportive		supportive\JA
---	DLI	-		=\DELIM
2374	TOK	care		care\N5S
---	DLI	-		=\DELIM
2375	TOK	alone		alone\JA
2376	TOK	group		group\N5S
2377	TOK	for		for\P
2378	TOK	a		a\AI---S
2379	TOK	cumulative		cumulative\JA
2380	TOK	median		median\N5S
2381	TOK	of		of\P
##	TAG	<num>
2382	TOK	15		15\X
##	TAG	</num>
---	DLE	(		=\DELIM
2383	TOK	range		range\N5S
##	TAG	<na type="function">
2384	TOK	1-168		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
2385	TOK	days		day\N5P
2386	TOK	and		and\CC
##	TAG	<num>
2387	TOK	11		11\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<na type="function">
2388	TOK	2-87		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
2389	TOK	days		day\N5P
---	DLD	,		=\DELIM
2390	TOK	respectively		respectively\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
2391	TOK	Discussion	BOS	discussion\N5S
tf	TOK		EOS	=\DELS
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
2393	TOK	This	BOS	this\AD---S
2394	TOK	study		study\N5S
2395	TOK	showed		show\VMF6A66
2396	TOK	that		that\CS
2397	TOK	treatment		treatment\N5S
2398	TOK	with		with\P
2399	TOK	irinotecan		irinotecan\JA
2400	TOK	and		and\CC
2401	TOK	supportive		supportive\JA
2402	TOK	care		care\N5S
2403	TOK	alone		alone\DGA7
---	DLD	,		=\DELIM
2404	TOK	compared		compare\VMC----
2405	TOK	with		with\P
2406	TOK	supportive		supportive\JA
2407	TOK	care		care\N5S
---	DLD	,		=\DELIM
2408	TOK	prolonged		prolong\VMF6A66
2409	TOK	the		the\AT---6
2410	TOK	life		life\N5S
2411	TOK	of		of\P
2412	TOK	patients		patient\N5P
2413	TOK	with		with\P
2414	TOK	metastatic		metastatic\JA
2415	TOK	colorectal		colorectal\JA
2416	TOK	cancer		cancer\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2417	TOK	This	BOS	this\AD---S
2418	TOK	benefit		benefit\N5S
2419	TOK	was		be\V6F-A66
2420	TOK	clinically		clinically\DGA7
2421	TOK	meaningful		meaningful\JA
2422	TOK	because		because\CS
2423	TOK	the		the\AT---6
2424	TOK	probability		probability\N5S
2425	TOK	of		of\P
2426	TOK	surviving		survive\VMG----
##	TAG	<num>
2427	TOK	1		1\X
##	TAG	</num>
2428	TOK	year		year\N5S
2429	TOK	was		be\V6F-A66
##	TAG	<na type="function">
2430	TOK	2·6		noanat\W
##	TAG	</na>
2431	TOK	times		time\N5P
2432	TOK	greater		great\JC
2433	TOK	in		in\P
2434	TOK	patients		patient\N5P
2435	TOK	given		give\VMC----
2436	TOK	irinotecan		irinotecan\N5S
2437	TOK	compared		compare\VMC----
2438	TOK	with		with\P
2439	TOK	that		that\RDS3N-
2440	TOK	of		of\P
2441	TOK	patients		patient\N5P
2442	TOK	given		give\VMC----
2443	TOK	supportive		supportive\JA
2444	TOK	care		care\N5S
2445	TOK	alone		alone\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2446	TOK	Other	BOS	other\JA
2447	TOK	efficacy		efficacy\N5S
2448	TOK	endpoints		endpoint\N5P
---	DLD	,		=\DELIM
2449	TOK	such		such\JA
2450	TOK	as		as\P
2451	TOK	survival		survival\N5S
2452	TOK	without		without\P
2453	TOK	weight		weight\N5S
2454	TOK	loss		loss\N5S
---	DLD	,		=\DELIM
2455	TOK	survival		survival\N5S
2456	TOK	without		without\P
2457	TOK	performance		performance\N5S
2458	TOK	status		status\N5S
2459	TOK	deterioration		deterioration\N5S
---	DLD	,		=\DELIM
2460	TOK	pain		pain\N5S
---	DLI	-		=\DELIM
2461	TOK	free		free\JA
2462	TOK	survival		survival\N5S
---	DLD	,		=\DELIM
2463	TOK	and		and\CC
2464	TOK	quality		quality\N5S
---	DLI	-		=\DELIM
2465	TOK	of		of\P
---	DLI	-		=\DELIM
2466	TOK	life		life\N5S
---	DLD	,		=\DELIM
2467	TOK	were		be\V6F-A66
2468	TOK	all		all\DGA7
2469	TOK	significantly		significantly\DGA7
2470	TOK	in		in\P
2471	TOK	favour		favour\N5S
2472	TOK	of		of\P
2473	TOK	irinotecan		irinotecan\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2474	TOK	The	BOS	the\AT---6
2475	TOK	survival		survival\N5S
2476	TOK	advantage		advantage\N5S
2477	TOK	for		for\P
2478	TOK	the		the\AT---6
2479	TOK	irinotecan		irinotecan\JA
2480	TOK	group		group\N5S
2481	TOK	remained		remain\VMF6A66
2482	TOK	highly		highly\DGA7
2483	TOK	significant		significant\JA
2484	TOK	after		after\P
2485	TOK	adjustment		adjustment\N5S
2486	TOK	of		of\P
2487	TOK	performance		performance\N5S
2488	TOK	status		status\N5S
---	DLD	,		=\DELIM
2489	TOK	a		a\AI---S
2490	TOK	well		well\DGA7
---	DLI	-		=\DELIM
2491	TOK	recognised		recognise\VMC----
2492	TOK	prognostic		prognostic\JA
2493	TOK	factor		factor\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2494	TOK	More	BOS	more\DDC7
2495	TOK	generally		generally\DGA7
---	DLD	,		=\DELIM
2496	TOK	the		the\AT---6
2497	TOK	multivariate		multivariate\JA
2498	TOK	regression		regression\N5S
2499	TOK	showed		show\VMF6A66
2500	TOK	that		that\CS
2501	TOK	the		the\AT---6
2502	TOK	difference		difference\N5S
2503	TOK	in		in\P
2504	TOK	survival		survival\N5S
2505	TOK	between		between\P
2506	TOK	the		the\AT---6
##	TAG	<num>
2507	TOK	two		two\X
##	TAG	</num>
2508	TOK	groups		group\N5P
2509	TOK	remained		remain\VMF6A66
2510	TOK	significant		significant\JA
2511	TOK	even		even\DGA7
2512	TOK	after		after\P
2513	TOK	adjusting		adjust\VMG----
2514	TOK	for		for\P
2515	TOK	the		the\AT---6
2516	TOK	effect		effect\N5S
2517	TOK	of		of\P
2518	TOK	well		well\DGA7
---	DLI	-		=\DELIM
2519	TOK	known		know\VMC----
2520	TOK	prognostic		prognostic\JA
2521	TOK	factors		factor\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2522	TOK	The	BOS	the\AT---6
2523	TOK	survival		survival\N5S
2524	TOK	data		data\N56
2525	TOK	were		be\V6F-A66
2526	TOK	also		also\DGA7
2527	TOK	consistent		consistent\JA
2528	TOK	with		with\P
2529	TOK	those		that\RDP3N-
2530	TOK	observed		observe\VMC----
2531	TOK	in		in\P
2532	TOK	the		the\AT---6
2533	TOK	phase		phase\N5S
##	TAG	<num>
2534	TOK	II		II\X
##	TAG	</num>
2535	TOK	studies		study\N5P
2536	TOK	of		of\P
2537	TOK	irinotecan		irinotecan\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2538	TOK	The	BOS	the\AT---6
2539	TOK	study		study\N5S
2540	TOK	also		also\DGA7
2541	TOK	showed		show\VMF6A66
2542	TOK	an		an\AI---S
2543	TOK	advantage		advantage\N5S
2544	TOK	for		for\P
2545	TOK	irinotecan		irinotecan\N5S
2546	TOK	for		for\P
2547	TOK	quality		quality\N5S
2548	TOK	of		of\P
2549	TOK	life		life\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2550	TOK	The	BOS	the\AT---6
2551	TOK	results		result\N5P
2552	TOK	were		be\V6F-A66
2553	TOK	consistent		consistent\JA
2554	TOK	with		with\P
2555	TOK	other		other\JA
2556	TOK	clinical		clinical\JA
2557	TOK	variables		variable\N5P
---	DLE	(		=\DELIM
2558	TOK	performance		performance\N5S
2559	TOK	status		status\N5S
2560	TOK	deterioration		deterioration\N5S
---	DLD	,		=\DELIM
2561	TOK	weight		weight\N5S
2562	TOK	loss		loss\N5S
---	DLD	,		=\DELIM
2563	TOK	and		and\CC
2564	TOK	pain		pain\N5S
2565	TOK	control		control\VMF6R66
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2566	TOK	The	BOS	the\AT---6
2567	TOK	analysis		analysis\N5S
2568	TOK	of		of\P
2569	TOK	the		the\AT---6
##	TAG	<name>
2570	TOK	EORTC QLQ-C30		EORTC_QLQ-C30\N46
##	TAG	</name>
2571	TOK	symptoms		symptom\N5P
2572	TOK	scale		scale\N5S
2573	TOK	was		be\V6F-A66
2574	TOK	consistent		consistent\JA
2575	TOK	with		with\P
2576	TOK	the		the\AT---6
2577	TOK	safety		safety\N5S
2578	TOK	data		data\N56
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2579	TOK	This	BOS	this\RDS3N-
2580	TOK	suggests		suggest\VMFDRS3
2581	TOK	that		that\CS
2582	TOK	the		the\AT---6
##	TAG	<name>
2583	TOK	EORTC QLQC30		EORTC_QLQC30\N46
##	TAG	</name>
2584	TOK	questionnaire		questionnaire\N5S
2585	TOK	is		be\V6FDRS3
2586	TOK	sensitive		sensitive\JA
---	DLD	,		=\DELIM
2587	TOK	contrary		contrary\N5S
2588	TOK	to		to\P
2589	TOK	a		a\AI---S
2590	TOK	previous		previous\JA
2591	TOK	report		report\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2592	TOK	The	BOS	the\AT---6
2593	TOK	safety		safety\N5S
2594	TOK	profile		profile\N5S
2595	TOK	of		of\P
2596	TOK	irinotecan		irinotecan\N5S
2597	TOK	was		be\V6F-A66
2598	TOK	acceptable		acceptable\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2599	TOK	The	BOS	the\AT---6
2600	TOK	incidence		incidence\N5S
2601	TOK	of		of\P
2602	TOK	treatment		treatment\N5S
---	DLD	-		=\DELIM
2603	TOK	related		relate\VMC----
2604	TOK	grade		grade\VMF6R66
##	TAG	<num>
2605	TOK	3		3\X
##	TAG	</num>
2606	TOK	or		or\CC
##	TAG	<num>
2607	TOK	4		4\X
##	TAG	</num>
2608	TOK	diarrhoea		diarrhoea\N5S
2609	TOK	with		with\P
2610	TOK	irinotecan		irinotecan\JA
---	DLE	(		=\DELIM
##	TAG	<num>
2611	TOK	21		21\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
2612	TOK	was		be\V6F-A66
2613	TOK	lower		low\JC
2614	TOK	than		than\CS
2615	TOK	that		that\RDS3N-
2616	TOK	reported		report\VMC----
2617	TOK	in		in\P
2618	TOK	previous		previous\JA
2619	TOK	studies		study\N5P
---	DLE	(		=\DELIM
##	TAG	<num>
2620	TOK	39		39\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2621	TOK	This	BOS	this\AD---S
2622	TOK	result		result\VMF6R66
---	DLD	,		=\DELIM
2623	TOK	observed		observe\VMC----
2624	TOK	in		in\P
2625	TOK	a		a\AI---S
2626	TOK	multicentre		multicentre\N5S
2627	TOK	trial		trial\N5S
---	DLD	,		=\DELIM
2628	TOK	is		be\V6FDRS3
2629	TOK	probably		probably\DGA7
2630	TOK	accounted		account\VMC----
2631	TOK	for		for\P
2632	TOK	by		by\P
2633	TOK	the		the\AT---6
2634	TOK	more		more\DDC7
2635	TOK	rigorous		rigorous\JA
2636	TOK	implementation		implementation\N5S
2637	TOK	of		of\P
2638	TOK	guidelines		guideline\N5P
2639	TOK	for		for\P
2640	TOK	the		the\AT---6
2641	TOK	management		management\N5S
2642	TOK	of		of\P
2643	TOK	diarrhoea		diarrhoea\N5S
2644	TOK	than		than\CS
2645	TOK	in		in\P
2646	TOK	earlier		early\JC
2647	TOK	studies		study\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2648	TOK	Grade	BOS	grade\N5S
##	TAG	<na type="function">
2649	TOK	3-4		noanat\W
##	TAG	</na>
2650	TOK	neutropenia		neutropenia\N5S
2651	TOK	was		be\V6F-A66
2652	TOK	reported		report\VMC----
2653	TOK	in		in\P
##	TAG	<num>
2654	TOK	22		22\X
##	TAG	</num>
---	DLD	%		=\DELIM
2655	TOK	and		and\CC
2656	TOK	grade		grade\VMF6R66
##	TAG	<na type="function">
2657	TOK	3-4		noanat\W
##	TAG	</na>
2658	TOK	vomiting		vomit\VMG----
2659	TOK	in		in\P
##	TAG	<na type="function">
2660	TOK	14% of		noanat\W
##	TAG	</na>
2661	TOK	patients		patient\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2662	TOK	Asthenia	BOS	asthenia\N5S
---	DLD	,		=\DELIM
2663	TOK	pain		pain\N5S
---	DLD	,		=\DELIM
2664	TOK	and		and\CC
2665	TOK	neurological		neurological\JA
2666	TOK	symptoms		symptom\N5P
2667	TOK	were		be\V6F-A66
2668	TOK	more		more\DDC7
2669	TOK	frequent		frequent\JA
2670	TOK	in		in\P
2671	TOK	the		the\AT---6
2672	TOK	supportive		supportive\JA
---	DLD	-		=\DELIM
2673	TOK	care		care\N5S
2674	TOK	group		group\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2675	TOK	Some	BOS	some\DGA7
2676	TOK	say		say\VMF6R66
2677	TOK	that		that\CS
2678	TOK	patients		patient\N5P
2679	TOK	with		with\P
2680	TOK	advanced		advance\VMC----
2681	TOK	cancer		cancer\N5S
2682	TOK	who		who\RW63N-
2683	TOK	are		be\V6FDR66
2684	TOK	treated		treat\VMC----
2685	TOK	with		with\P
2686	TOK	supportive		supportive\JA
2687	TOK	care		care\N5S
2688	TOK	alone		alone\DGA7
2689	TOK	will		will\VOFDR66
2690	TOK	have		have\VMI----
2691	TOK	a		a\AI---S
2692	TOK	short		short\JA
2693	TOK	but		but\CC
2694	TOK	peaceful		peaceful\JA
2695	TOK	end		end\N5S
2696	TOK	to		to\P
2697	TOK	their		their\APP3N6
2698	TOK	life		life\N5S
---	DLD	,		=\DELIM
2699	TOK	protected		protect\VMC----
2700	TOK	from		from\P
2701	TOK	the		the\AT---6
2702	TOK	side		side\N5S
2703	TOK	effects		effect\N5P
2704	TOK	of		of\P
2705	TOK	chemotherapy		chemotherapy\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2706	TOK	Our	BOS	our\APP1N6
2707	TOK	study		study\N5S
2708	TOK	showed		show\VMF6A66
2709	TOK	that		that\CS
2710	TOK	as		as\DGA7
2711	TOK	many		many\AI---P
2712	TOK	as		as\P
##	TAG	<na type="function">
2713	TOK	67% of		noanat\W
##	TAG	</na>
2714	TOK	patients		patient\N5P
2715	TOK	receiving		receive\VMG----
2716	TOK	supportive		supportive\JA
2717	TOK	care		care\N5S
2718	TOK	experienced		experience\VMF6A66
2719	TOK	severe		severe\JA
2720	TOK	symptoms		symptom\N5P
2721	TOK	and		and\CC
2722	TOK	as		as\P
2723	TOK	a		a\AI---S
2724	TOK	result		result\N5S
---	DLD	,		=\DELIM
##	TAG	<num>
2725	TOK	63		63\X
##	TAG	</num>
---	DLD	%		=\DELIM
2726	TOK	were		be\V6F-A66
2727	TOK	admitted		admit\VMC----
2728	TOK	for		for\P
2729	TOK	a		a\AI---S
2730	TOK	median		median\N5S
2731	TOK	of		of\P
##	TAG	<num>
2732	TOK	11		11\X
##	TAG	</num>
2733	TOK	days		day\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2734	TOK	Furthermore	BOS	furthermore\DGA7
---	DLD	,		=\DELIM
2735	TOK	irinotecan		irinotecan\N5S
2736	TOK	improved		improve\VMF6A66
2737	TOK	the		the\AT---6
2738	TOK	symptoms		symptom\N5P
2739	TOK	of		of\P
2740	TOK	patients		patient\N5P
2741	TOK	and		and\CC
2742	TOK	delayed		delay\VMF6A66
2743	TOK	the		the\AT---6
2744	TOK	onset		onset\N5S
2745	TOK	of		of\P
2746	TOK	tumour		tumour\N5S
---	DLI	-		=\DELIM
2747	TOK	related		relate\VMC----
2748	TOK	symptoms		symptom\N5P
2749	TOK	such		such\RIS3N-
2750	TOK	as		as\P
2751	TOK	performance		performance\N5S
---	DLI	-		=\DELIM
2752	TOK	status		status\N5S
2753	TOK	deterioration		deterioration\N5S
---	DLD	,		=\DELIM
2754	TOK	weight		weight\N5S
2755	TOK	loss		loss\N5S
---	DLD	,		=\DELIM
2756	TOK	and		and\CC
2757	TOK	pain		pain\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2758	TOK	These	BOS	this\AD---P
2759	TOK	data		data\N56
2760	TOK	were		be\V6F-A66
2761	TOK	supported		support\VMC----
2762	TOK	by		by\P
2763	TOK	the		the\AT---6
2764	TOK	quality		quality\N5S
---	DLI	-		=\DELIM
2765	TOK	of		of\P
---	DLI	-		=\DELIM
2766	TOK	life		life\N5S
2767	TOK	analysis		analysis\N5S
2768	TOK	which		which\RW63N-
2769	TOK	suggested		suggest\VMF6A66
2770	TOK	that		that\CS
2771	TOK	the		the\AT---6
2772	TOK	side		side\N5S
---	DLI	-		=\DELIM
2773	TOK	effects		effect\N5P
2774	TOK	of		of\P
2775	TOK	irinotecan		irinotecan\N5S
2776	TOK	were		be\V6F-A66
2777	TOK	favourably		favourably\JA
2778	TOK	balanced		balance\VMC----
2779	TOK	by		by\P
2780	TOK	reduced		reduce\VMC----
2781	TOK	tumour		tumour\N5S
---	DLI	-		=\DELIM
2782	TOK	related		relate\VMC----
2783	TOK	events		event\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2784	TOK	We	BOS	we\RPP1NN
2785	TOK	have		have\V6F6R66
2786	TOK	shown		show\VMC----
2787	TOK	a		a\AI---S
2788	TOK	survival		survival\N5S
2789	TOK	advantage		advantage\N5S
2790	TOK	and		and\CC
2791	TOK	a		a\AI---S
2792	TOK	clinical		clinical\JA
2793	TOK	benefit		benefit\N5S
2794	TOK	from		from\P
2795	TOK	second		second\MOS
---	DLI	-		=\DELIM
2796	TOK	line		line\N5S
2797	TOK	chemotherapy		chemotherapy\N5S
2798	TOK	in		in\P
2799	TOK	patients		patient\N5P
2800	TOK	with		with\P
2801	TOK	metastatic		metastatic\JA
2802	TOK	colorectal		colorectal\JA
2803	TOK	cancer		cancer\N5S
##	TAG	<loc pos="DGA7">
2804	TOK	no longer		no_longer\DGA7
##	TAG	</loc>
2805	TOK	responding		respond\VMG----
2806	TOK	to		to\P
2807	TOK	fluorouracil		fluorouracil\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2808	TOK	Many	BOS	many\AI---P
2809	TOK	patients		patient\N5P
2810	TOK	had		have\V6F6A66
2811	TOK	poor		poor\JA
2812	TOK	prognostic		prognostic\JA
2813	TOK	factors		factor\N5P
---	DLD	,		=\DELIM
2814	TOK	which		which\RW63N-
2815	TOK	implies		imply\VMFDRS3
2816	TOK	that		that\CS
2817	TOK	the		the\AT---6
2818	TOK	results		result\N5P
2819	TOK	will		will\VOFDR66
2820	TOK	be		be\VMI----
2821	TOK	applicable		applicable\JA
2822	TOK	in		in\P
2823	TOK	the		the\AT---6
2824	TOK	daily		daily\JA
2825	TOK	practice		practice\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2826	TOK	The	BOS	the\AT---6
2827	TOK	value		value\N5S
2828	TOK	of		of\P
2829	TOK	irinotecan		irinotecan\N5S
2830	TOK	was		be\V6F-A66
2831	TOK	confirmed		confirm\VMC----
2832	TOK	in		in\P
2833	TOK	terms		term\N5P
2834	TOK	of		of\P
2835	TOK	survival		survival\N5S
---	DLD	,		=\DELIM
2836	TOK	quality		quality\N5S
2837	TOK	of		of\P
2838	TOK	life		life\N5S
---	DLD	,		=\DELIM
2839	TOK	and		and\CC
2840	TOK	other		other\JA
2841	TOK	clinical		clinical\JA
2842	TOK	variables		variable\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
2843	TOK	Irinotecan	BOS	Irinotecan\N46
##	TAG	</name>
2844	TOK	can		can\VOFDR66
2845	TOK	therefore		therefore\DGA7
2846	TOK	be		be\VMI----
2847	TOK	recommended		recommend\VMC----
2848	TOK	as		as\P
2849	TOK	the		the\AT---6
2850	TOK	standard		standard\JA
2851	TOK	second		second\MOS
---	DLI	-		=\DELIM
2852	TOK	line		line\N5S
2853	TOK	therapy		therapy\N5S
2854	TOK	in		in\P
2855	TOK	colorectal		colorectal\JA
2856	TOK	cancer		cancer\N5S
2857	TOK	and		and\CC
2858	TOK	as		as\P
2859	TOK	a		a\AI---S
2860	TOK	new		new\JA
2861	TOK	reference		reference\N5S
2862	TOK	for		for\P
2863	TOK	forthcoming		forthcoming\JA
2864	TOK	clinical		clinical\JA
2865	TOK	trials		trial\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
2866	TOK	Table	BOS	table\VMF6R66
##	TAG	<num>
2867	TOK	1	EOS	1\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
2869	TOK	Safety	BOS	safety\N5S
2870	TOK	guidelines		guideline\N5P
2871	TOK	for		for\P
2872	TOK	treatment		treatment\N5S
2873	TOK	with		with\P
2874	TOK	irinotecan	EOS	irinotecan\N5S
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
2876	TOK	Side	BOS	side\N5S
2877	TOK	effect		effect\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2878	TOK	Treatment	BOS	treatment\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2879	TOK	Cholinergic	BOS	cholinergic\JA
2880	TOK	syndrome		syndrome\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2881	TOK	Atropine	BOS	atropine\N5S
2882	TOK	sulphate		sulphate\N5S
---	DLE	(		=\DELIM
##	TAG	<na type="function">
2883	TOK	0·25		noanat\W
##	TAG	</na>
2884	TOK	mg		mg\N5S
2885	TOK	subcutaneously		subcutaneously\DGA7
---	DLD	)		=\DELIM
---	DLD	,		=\DELIM
2886	TOK	if		if\CS
2887	TOK	severe		severe\JA
---	DLD	,		=\DELIM
2888	TOK	prophylactic		prophylactic\JA
2889	TOK	treatment		treatment\N5S
2890	TOK	at		at\P
2891	TOK	further		further\JA
2892	TOK	cycles		cycle\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
2893	TOK	Nausea/vomiting	BOS	Nausea/vomiting\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2894	TOK	Systemic	BOS	systemic\JA
2895	TOK	prophylactic		prophylactic\JA
2896	TOK	antiemetics		antiemetic\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2897	TOK	First	BOS	first\MOS
2898	TOK	loose		loose\JA
2899	TOK	stool		stool\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2901	TOK	Early	BOS	early\JA
2902	TOK	high		high\JA
---	DLI	-		=\DELIM
2903	TOK	dose		dose\N5S
2904	TOK	loperamide		loperamide\N5S
---	DLE	(		=\DELIM
##	TAG	<num>
2905	TOK	4		4\X
##	TAG	</num>
2906	TOK	mg		mg\N5S
2907	TOK	at		at\P
2908	TOK	the		the\AT---6
2909	TOK	first		first\MOS
2910	TOK	loose		loose\JA
2911	TOK	stool		stool\N5S
---	DLD	,		=\DELIM
2912	TOK	then		then\DGA7
##	TAG	<num>
2913	TOK	2		2\X
##	TAG	</num>
##	TAG	<loc pos="N56">
2914	TOK	mg		mg\N56
##	TAG	</loc>
2915	TOK	every		every\AG---S
##	TAG	<num>
2916	TOK	2		2\X
##	TAG	</num>
2917	TOK	h		h\N5S
2918	TOK	for		for\P
##	TAG	<num>
2919	TOK	12		12\X
##	TAG	</num>
2920	TOK	h		h\N5S
2921	TOK	after		after\P
2922	TOK	the		the\AT---6
2923	TOK	last		last\JA
2924	TOK	loose		loose\JA
2925	TOK	stool		stool\N5S
2926	TOK	for		for\P
2927	TOK	a		a\AI---S
2928	TOK	maximum		maximum\N5S
2929	TOK	of		of\P
##	TAG	<num>
2930	TOK	48		48\X
##	TAG	</num>
2931	TOK	h		h\N5S
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2932	TOK	Diarrhoea	BOS	diarrhoea\N5S
2933	TOK	for		for\P
2934	TOK	>		noanat\W
2935	TOK	24h.	EOS	noanat\W
##	TAG	</s>
##	TAG	<s>
2937	TOK	Oral	BOS	oral\JA
2938	TOK	prophylactic		prophylactic\JA
2939	TOK	broad		broad\JA
---	DLI	-		=\DELIM
2940	TOK	spectrum		spectrum\N5S
2941	TOK	antibiotherapyeg		antibiotherapyeg\N5P
---	DLD	,		=\DELIM
2942	TOK	fluoroquinolone		fluoroquinolone\N5S
---	DLE	(		=\DELIM
2943	TOK	to		to\P
2944	TOK	prevent		prevent\VMI----
2945	TOK	the		the\AT---6
2946	TOK	risk		risk\N5S
2947	TOK	of		of\P
2948	TOK	severe		severe\JA
2949	TOK	infection		infection\N5S
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2950	TOK	Diarrhoea	BOS	diarrhoea\N5S
2951	TOK	for		for\P
2952	TOK	>		noanat\W
2953	TOK	48h.	EOS	noanat\W
##	TAG	</s>
##	TAG	<s>
2955	TOK	Admission	BOS	admission\N5S
2956	TOK	to		to\P
2957	TOK	hospital		hospital\N5S
2958	TOK	for		for\P
2959	TOK	parenteral		parenteral\JA
2960	TOK	support		support\N5S
2961	TOK	and		and\CC
2962	TOK	replacement		replacement\N5S
2963	TOK	of		of\P
2964	TOK	antidiarrhoeal		antidiarrhoeal\JA
2965	TOK	treatmenteg		treatmenteg\N5P
---	DLD	,		=\DELIM
2966	TOK	octreotide		octreotide\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2967	TOK	Grade	BOS	grade\VMF6R66
##	TAG	<num>
2968	TOK	4		4\X
##	TAG	</num>
2969	TOK	neutropenia		neutropenia\N5S
2970	TOK	or		or\CC
2971	TOK	grade		grade\VMF6R66
##	TAG	<num>
2972	TOK	3		3\X
##	TAG	</num>
2973	TOK	or		or\CC
##	TAG	<num>
2974	TOK	4		4\X
##	TAG	</num>
2975	TOK	diarrhoea		diarrhoea\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2976	TOK	Dose	BOS	dose\N5S
2977	TOK	reduction		reduction\N5S
2978	TOK	at		at\P
2979	TOK	further		further\JA
2980	TOK	cycles		cycle\N5P
---	DLD	:		=\DELIM
##	TAG	<num>
2981	TOK	300		300\X
##	TAG	</num>
##	TAG	<loc pos="N56">
2982	TOK	mg/m2		mg/m2\N56
##	TAG	</loc>
2983	TOK	then		then\DGA7
##	TAG	<num>
2984	TOK	250		250\X
##	TAG	</num>
##	TAG	<loc pos="N56">
2985	TOK	mg/m2		mg/m2\N56
##	TAG	</loc>
---	DLE	(		=\DELIM
2986	TOK	or		or\CC
##	TAG	<num>
2987	TOK	250		250\X
##	TAG	</num>
##	TAG	<loc pos="N56">
2988	TOK	mg/m2		mg/m2\N56
##	TAG	</loc>
---	DLE	,		=\DELIM
2989	TOK	then		then\DGA7
##	TAG	<num>
2990	TOK	200		200\X
##	TAG	</num>
##	TAG	<loc pos="N56">
2991	TOK	mg/m2		mg/m2\N56
##	TAG	</loc>
2992	TOK	if		if\CS
2993	TOK	start		start\N5S
2994	TOK	dose		dose\N5S
##	TAG	<num>
2995	TOK	300		300\X
##	TAG	</num>
##	TAG	<loc pos="N56">
2996	TOK	mg/m2		mg/m2\N56
##	TAG	</loc>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
2997	TOK	Table	BOS	table\VMF6R66
##	TAG	<num>
2998	TOK	2	EOS	2\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
3000	TOK	Baseline	BOS	baseline\N5S
3001	TOK	characteristics	EOS	characteristic\N5P
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3003	TOK	Irinotecan	BOS	Irinotecan\N46
##	TAG	</name>
---	DLE	(		=\DELIM
##	TAG	<na type="equation">
3004	TOK	n=189		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3006	TOK	Supportive	BOS	supportive\JA
3007	TOK	care		care\N5S
---	DLE	(		=\DELIM
##	TAG	<na type="equation">
3008	TOK	n=90		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3010	TOK	Sex	BOS	sex\N5S
---	DLE	(		=\DELIM
3011	TOK	men/women		men/women\N5P
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3012	TOK	Median	BOS	median\N5S
3013	TOK	age		age\N5S
---	DLE	(		=\DELIM
3014	TOK	range		range\VMF6R66
---	DLD	,		=\DELIM
3015	TOK	years		year\N5P
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3016	TOK	WHO	BOS	who\RW63N-
3017	TOK	performance		performance\N5S
3018	TOK	status		status\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3019	TOK	Weight	BOS	weight\N5S
3020	TOK	loss		loss\N5S
##	TAG	<num>
3021	TOK	>5		>5\X
##	TAG	</num>
---	DLD	%		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3022	TOK	With	BOS	with\P
3023	TOK	symptoms		symptom\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3024	TOK	Primary	BOS	primary\JA
3025	TOK	tumour		tumour\N5S
3026	TOK	site		site\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3027	TOK	Colon	BOS	colon\N5S
3028	TOK	right		right\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3029	TOK	Colon	BOS	colon\N5S
3030	TOK	left		leave\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3031	TOK	Rectum	BOS	rectum\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3032	TOK	Number	BOS	number\N5S
3033	TOK	of		of\P
3034	TOK	organs		organ\N5P
3035	TOK	involved		involve\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3036	TOK	Sites	BOS	site\N5P
3037	TOK	of		of\P
3038	TOK	metastases		metastasis\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3039	TOK	Liver	BOS	liver\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3040	TOK	Lung	BOS	lung\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3041	TOK	Peritoneum	BOS	peritoneum\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3042	TOK	CEA	BOS	CEA\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3043	TOK	Median	BOS	median\N5S
##	TAG	<name>
3044	TOK	CEA		CEA\N46
##	TAG	</name>
3045	TOK	concentration		concentration\N5S
---	DLE	(		=\DELIM
3046	TOK	range		range\VMF6R66
---	DLD	;		=\DELIM
##	TAG	<na type="function">
3047	TOK	mg/L		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3048	TOK	Documentation	BOS	documentation\N5S
3049	TOK	of		of\P
3050	TOK	tumour		tumour\N5S
3051	TOK	progression		progression\N5S
3052	TOK	by		by\P
##	TAG	<name>
3053	TOK	CEA		CEA\N46
##	TAG	</name>
3054	TOK	increase		increase\N5S
3055	TOK	only		only\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3056	TOK	Mean	BOS	mean\JA
3057	TOK	increase		increase\VMF6R66
---	DLE	(		=\DELIM
##	TAG	<name>
3058	TOK	CEArand/CEAref		CEArand/CEAref\N46
##	TAG	</name>
---	DLE	)		=\DELIM
3059	TOK	for		for\P
3060	TOK	those		that\RDP3N-
3061	TOK	assessed		assess\VMC----
3062	TOK	by		by\P
##	TAG	<name>
3063	TOK	CEA		CEA\N46
##	TAG	</name>
3064	TOK	only		only\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3065	TOK	Documented	BOS	document\VMC----
3066	TOK	tumour		tumour\N5S
3067	TOK	progression		progression\N5S
3068	TOK	while		while\CS
3069	TOK	on		on\P
3070	TOK	previous		previous\JA
3071	TOK	fluorouracil		fluorouracil\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3072	TOK	Previous	BOS	previous\JA
3073	TOK	treatment		treatment\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3074	TOK	Surgery	BOS	surgery\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3075	TOK	Radiotherapy	BOS	radiotherapy\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3076	TOK	Chemotherapy	BOS	chemotherapy\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3077	TOK	Adjuvant	BOS	adjuvant\N5S
3078	TOK	only		only\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3079	TOK	One	BOS	one\MCS
3080	TOK	regimen		regimen\N5S
3081	TOK	for		for\P
3082	TOK	metastatic		metastatic\JA
3083	TOK	disease		disease\N5S
3084	TOK	with		with\P
3085	TOK	or		or\CC
3086	TOK	without		without\P
3087	TOK	adjuvant		adjuvant\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<num>
3088	TOK	>2	BOS	>2\X
##	TAG	</num>
3089	TOK	regimens		regimen\N5P
3090	TOK	for		for\P
3091	TOK	metastatic		metastatic\JA
3092	TOK	disease		disease\N5S
3093	TOK	with		with\P
3094	TOK	or		or\CC
3095	TOK	without		without\P
3096	TOK	adjuvant		adjuvant\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3097	TOK	Best	BOS	good\JS
3098	TOK	response		response\N5S
3099	TOK	to		to\P
3100	TOK	previous		previous\JA
3101	TOK	fluorouracil		fluorouracil\N5S
3102	TOK	for		for\P
3103	TOK	metastatic		metastatic\JA
3104	TOK	disease		disease\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3106	TOK	Complete/partial	BOS	Complete/partial\N46
##	TAG	</name>
3107	TOK	regression		regression\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3108	TOK	Stabilisation	BOS	Stabilisation\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3109	TOK	Progression	BOS	progression\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3110	TOK	Abnormal	BOS	abnormal\JA
3111	TOK	biological		biological\JA
3112	TOK	value		value\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3113	TOK	Haemoglobin	BOS	haemoglobin\N5S
3114	TOK	xxx		noanat\W
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3116	TOK	White	BOS	white\JA
3117	TOK	blood		blood\N5S
3118	TOK	cells		cell\N5P
##	TAG	<num>
3119	TOK	>83109		>83109\X
##	TAG	</num>
---	DLE	/		=\DELIM
3120	TOK	L		L\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3121	TOK	LDH/IUNL	BOS	LDH/IUNL\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3122	TOK	Alkaline	BOS	alkaline\JA
3123	TOK	phosphatases		phosphatase\N5P
3124	TOK	>		noanat\W
##	TAG	<name pos="N46" expansion="institutional upper normal limit">
3125	TOK	IUNL		IUNL\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3126	TOK	CEA	BOS	CEA\N5S
3127	TOK	>		noanat\W
##	TAG	<num>
3128	TOK	10		10\X
##	TAG	</num>
3129	TOK	mg/L		mg/L\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3130	TOK	Median	BOS	median\N5S
3131	TOK	haemoglobin		haemoglobin\N5S
3132	TOK	concentration		concentration\N5S
---	DLE	(		=\DELIM
3133	TOK	range		range\VMF6R66
---	DLD	;		=\DELIM
##	TAG	<na type="function">
3134	TOK	g/L		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
3135	TOK	Table	BOS	table\VMF6R66
##	TAG	<num>
3136	TOK	3	EOS	3\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
3138	TOK	Multivariate	BOS	multivariate\JA
##	TAG	<name>
3139	TOK	Cox		Cox\N46
##	TAG	</name>
3140	PGR	's		genmark\GENMARK
3141	TOK	analysis	EOS	analysis\N5S
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3143	TOK	Risk.	BOS	Risk.\N46
##	TAG	</name>
3144	TOK	ratio		ratio\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<list>
##	TAG	<item label="p.">
##	TAG	</item>
##	TAG	</list>
##	TAG	<p>
##	TAG	<s>
3145	TOK	Treatment	BOS	treatment\N5S
3146	TOK	group		group\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3147	TOK	Irinotecan	BOS	Irinotecan\N46
##	TAG	</name>
3148	TOK	and		and\CC
3149	TOK	supportive		supportive\JA
3150	TOK	care		care\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3151	TOK	Supportive	BOS	supportive\JA
3152	TOK	care		care\N5S
3153	TOK	alone		alone\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3154	TOK	Weight	BOS	weight\N5S
3155	TOK	loss		loss\N5S
3156	TOK	during		during\P
3157	TOK	previous		previous\JA
##	TAG	<num>
3158	TOK	3		3\X
##	TAG	</num>
3159	TOK	months		month\N5P
---	DLE	(		=\DELIM
---	DLD	%		=\DELIM
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3160	TOK	WHO	BOS	who\RW63N-
3161	TOK	performance		performance\N5S
3162	TOK	status		status\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3163	TOK	Haemoglobin	BOS	haemoglobin\N5S
---	DLE	(		=\DELIM
##	TAG	<na type="function">
3164	TOK	g/L		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3165	TOK	Liver	BOS	liver\N5S
3166	TOK	metastases		metastasis\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3167	TOK	Alkaline	BOS	alkaline\JA
3168	TOK	phosphatases		phosphatase\N5P
---	DLE	(		=\DELIM
3169	TOK	3UINL		3UINL\N5P
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3170	TOK	Number	BOS	number\N5S
3171	TOK	of		of\P
3172	TOK	organs		organ\N5P
3173	TOK	involved		involve\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
3174	TOK	Table	BOS	table\VMF6R66
##	TAG	<num>
3175	TOK	4	EOS	4\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
3177	TOK	Worst	BOS	bad\JS
3178	TOK	score		score\N56
3179	TOK	during		during\P
3180	TOK	study		study\N5S
3181	TOK	for		for\P
3182	TOK	each		each\AG---S
##	TAG	<name>
3183	TOK	EORTC QLQ-C30		EORTC_QLQ-C30\N46
##	TAG	</name>
3184	TOK	scale	EOS	scale\N5S
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3186	TOK	Irinotecan	BOS	Irinotecan\N46
##	TAG	</name>
---	DLE	(		=\DELIM
##	TAG	<na type="equation">
3187	TOK	n=158		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
3188	TOK	mean		mean\JA
---	DLE	(		=\DELIM
##	TAG	<name>
3189	TOK	SE		SE\N46
##	TAG	</name>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3191	TOK	Supportive	BOS	supportive\JA
3192	TOK	care		care\N5S
3193	TOK	alone		alone\DGA7
---	DLE	(		=\DELIM
##	TAG	<na type="equation">
3194	TOK	n=73		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
3195	TOK	mean		mean\JA
---	DLE	(		=\DELIM
##	TAG	<name>
3196	TOK	SE		SE\N46
##	TAG	</name>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<list>
##	TAG	<item label="p.">
##	TAG	</item>
##	TAG	</list>
##	TAG	<p>
##	TAG	<s>
3198	TOK	Functioning	BOS	function\VMG----
3199	TOK	scale		scale\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3200	TOK	Physical	BOS	physical\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3201	TOK	Role	BOS	role\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3202	TOK	Cognitive	BOS	cognitive\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3203	TOK	Emotional	BOS	emotional\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3204	TOK	Social	BOS	social\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3205	TOK	Global	BOS	global\JA
3206	TOK	quality		quality\N5S
3207	TOK	of		of\P
3208	TOK	life		life\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3209	TOK	Symptoms	BOS	symptom\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3210	TOK	Fatigue	BOS	fatigue\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3211	TOK	Nausea/vomiting	BOS	Nausea/vomiting\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3212	TOK	Pain	BOS	pain\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3213	TOK	Dyspnoea	BOS	dyspnoea\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3214	TOK	Sleep	BOS	sleep\N5S
3215	TOK	disturbance		disturbance\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3216	TOK	Appetite	BOS	appetite\N5S
3217	TOK	loss		loss\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3218	TOK	Constipation	BOS	constipation\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3219	TOK	Diarrhoea	BOS	diarrhoea\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3220	TOK	Financial	BOS	financial\JA
3221	TOK	impact		impact\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
3222	TOK	Table	BOS	table\VMF6R66
##	TAG	<num>
3223	TOK	5	EOS	5\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
3225	TOK	Patients	BOS	patient\N5P
3226	TOK	with		with\P
##	TAG	<name pos="N46" type="organization">
3227	TOK	National Cancer Institute		National_Cancer_Institute\N46
##	TAG	</name>
3228	TOK	common		common\JA
3229	TOK	toxicity		toxicity\N5S
3230	TOK	criteria		criterion\N5P
3231	TOK	grade		grade\VMF6R66
##	TAG	<num>
3232	TOK	3		3\X
##	TAG	</num>
3233	TOK	or		or\CC
##	TAG	<num>
3234	TOK	4	EOS	4\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
3236	TOK	Adverse	BOS	adverse\JA
3237	TOK	event		event\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
3238	TOK	Irinotecan	BOS	Irinotecan\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3239	TOK	Supportive	BOS	supportive\JA
3240	TOK	care		care\N5S
3241	TOK	alone		alone\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3242	TOK	Anaemia	BOS	anaemia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3243	TOK	Leukopenia/neutropenia	BOS	Leukopenia/neutropenia\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3244	TOK	Thrombocytopenia	BOS	thrombocytopenia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3246	TOK	Fever	BOS	fever\N5S
3247	TOK	or		or\CC
3248	TOK	infection		infection\N5S
3249	TOK	with		with\P
3250	TOK	grade		grade\VMI----
##	TAG	<num>
3251	TOK	3		3\X
##	TAG	</num>
3252	TOK	or		or\CC
3253	TOK	neutropenia		neutropenia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3254	TOK	Nausea	BOS	nausea\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3255	TOK	Vomiting	BOS	vomit\VMG----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3257	TOK	Diarrhoea	BOS	diarrhoea\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3258	TOK	Constipation	BOS	constipation\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3260	TOK	Cholinergic	BOS	cholinergic\JA
3261	TOK	syndrome		syndrome\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3262	TOK	Asthenia	BOS	asthenia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3263	TOK	Mucositis	BOS	Mucositis\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3264	TOK	Anorexia	BOS	anorexia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3265	TOK	Cutaneous	BOS	cutaneous\JA
3266	TOK	signs		sign\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3267	TOK	Neurological	BOS	neurological\JA
3268	TOK	symptoms		symptom\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3269	TOK	Cardiovascular	BOS	cardiovascular\JA
3270	TOK	symptoms		symptom\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3271	TOK	Pain	BOS	pain\N5S
---	DLE	(		=\DELIM
3272	TOK	abdominal		abdominal\JA
3273	TOK	excluded		exclude\VMF6A66
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3274	TOK	Abdominal	BOS	abdominal\JA
3275	TOK	pain		pain\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3276	TOK	Infection	BOS	infection\N5S
---	DLE	(		=\DELIM
3277	TOK	without		without\P
3278	TOK	grade		grade\VMI----
##	TAG	<num>
3279	TOK	3		3\X
##	TAG	</num>
3280	TOK	or		or\CC
##	TAG	<num>
3281	TOK	4		4\X
##	TAG	</num>
3282	TOK	neutropenia		neutropenia\N5S
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3283	TOK	Any	BOS	any\AG---6
3284	TOK	grade		grade\VMF6R66
##	TAG	<num>
3285	TOK	3		3\X
##	TAG	</num>
3286	TOK	or		or\CC
##	TAG	<num>
3287	TOK	4		4\X
##	TAG	</num>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
3288	TOK	Figure	BOS	figure\N5S
##	TAG	<num>
3289	TOK	1	EOS	1\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
3291	TOK	Trial	BOS	trial\N5S
3292	TOK	profile	EOS	profile\N5S
##	TAG	</head>
##	TAG	<head>
3294	TOK	Figure	BOS	figure\N5S
##	TAG	<num>
3295	TOK	2	EOS	2\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
3297	TOK	Probability	BOS	probability\N5S
3298	TOK	of		of\P
3299	TOK	survival		survival\N5S
3300	TOK	of		of\P
3301	TOK	the		the\AT---6
##	TAG	<num>
3302	TOK	279		279\X
##	TAG	</num>
3303	TOK	patients	EOS	patient\N5P
##	TAG	</head>
##	TAG	<head>
3305	TOK	Figure	BOS	figure\N5S
##	TAG	<num>
3306	TOK	3	EOS	3\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
3308	TOK	Probability	BOS	probability\N5S
3309	TOK	of		of\P
3310	TOK	survival		survival\N5S
##	TAG	<loc pos="P">
3311	TOK	according to		according_to\P
##	TAG	</loc>
3312	TOK	performance		performance\N5S
3313	TOK	status	EOS	status\N5S
##	TAG	</head>
##	TAG	<head>
3315	TOK	Figure	BOS	figure\N5S
##	TAG	<num>
3316	TOK	4	EOS	4\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
3318	TOK	Probability	BOS	probability\N5S
3319	TOK	of		of\P
3320	TOK	pain		pain\N5S
---	DLI	-		=\DELIM
3321	TOK	free		free\JA
3322	TOK	survival		survival\N5S
3323	TOK	in		in\P
##	TAG	<num>
3324	TOK	116		116\X
##	TAG	</num>
3325	TOK	patients		patient\N5P
3326	TOK	without		without\P
3327	TOK	pain		pain\N5S
3328	TOK	at		at\P
3329	TOK	baseline	EOS	baseline\N5S
##	TAG	</head>
##	TAG	</div1>
